Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	EPS15 SPTA1 ADGRV1 ITPR1 FAT1 HEG1 FBLN2 HMCN2 LPCAT2 TESC PADI1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 DUOX2 ANXA8 BCAN RHOT2 ESYT3 CELSR3 PCDHGA12 PADI2 PCDH7 AGRN CDH15	1.10e-06	749	253	27	GO:0005509
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH5 DYNC1H1 DYNC2H1 DNAH17 DNAH11	2.35e-06	18	253	5	GO:0008569
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH5 DYNC1H1 DYNC2H1 DNAH17 HTT DNAH11	6.52e-06	37	253	6	GO:0045505
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH5 DYNC1H1 DYNC2H1 DNAH17 DNAH11	2.43e-05	28	253	5	GO:0051959
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	PPARGC1A TACC1 DNMT1 NSD1 ARRB1 PADI2	5.44e-05	53	253	6	GO:0030331
GeneOntologyMolecularFunction	transmembrane transporter binding	KCNB2 ITPR1 KCNB1 MPP2 FLNA ANK2 ANK3 ARRB1 AGRN HTT	7.09e-05	172	253	10	GO:0044325
GeneOntologyMolecularFunction	ATP-dependent activity	MYH3 ABCA1 COQ8B MCM3 UBA7 CHD6 DNAH5 DYNC1H1 HSP90AA4P IPO8 DYNC2H1 CHD9 CHD8 MLH3 DNAH17 DNAI2 AACS DHX34 ATP5F1C DNAH11	1.17e-04	614	253	20	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH3 DNAH5 DYNC1H1 DYNC2H1 DNAH17 DNAI2 MYO16 DNAH11	1.31e-04	118	253	8	GO:0003774
GeneOntologyMolecularFunction	actin filament binding	MYH3 ABL1 ABL2 SPTA1 SHROOM4 AFDN FLII FLNA ANXA8 TRPV4 MYO16	1.59e-04	227	253	11	GO:0051015
GeneOntologyMolecularFunction	succinate-semialdehyde dehydrogenase (NAD+) activity	SUCLG2 ALDH5A1	1.60e-04	2	253	2	GO:0004777
GeneOntologyMolecularFunction	succinate-semialdehyde dehydrogenase [NAD(P)+] activity	SUCLG2 ALDH5A1	1.60e-04	2	253	2	GO:0009013
GeneOntologyMolecularFunction	microtubule motor activity	DNAH5 DYNC1H1 DYNC2H1 DNAH17 DNAI2 DNAH11	2.60e-04	70	253	6	GO:0003777
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH3 ABCA1 COQ8B MCM3 CHD6 DNAH5 DYNC1H1 HSP90AA4P DYNC2H1 CHD9 CHD8 MLH3 DHX34 ATP5F1C DNAH11	5.35e-04	441	253	15	GO:0016887
GeneOntologyBiologicalProcess	neuron development	ABL1 ABL2 MYCBP2 DAB2 LGR4 CHAT ADGRV1 CUL7 ITPR1 KIRREL3 MRTFB HMCN2 KCNB1 SNAP91 NFATC4 PTPRZ1 NFIX SEC24B AFDN PLD2 MTCH1 PREX1 PLXNA1 FLNA LRP12 FAT4 ANK3 ATCAY RTN4 BCAN SIN3A NR3C1 SHOC2 TDP2 CELSR3 RP1L1 KNDC1 TRPV4 SMO AGRN MYO16 HTT LGI1	5.29e-08	1463	250	43	GO:0048666
GeneOntologyBiologicalProcess	brain development	STK36 ABL1 ABL2 COQ8B SHROOM4 KIRREL3 MRTFB NFIX SEC24B AFDN TACC1 DNAH5 PLXNA1 SOX6 FLNA FAT4 MCPH1 DYNC2H1 RTN4 DUOX2 CHD8 TACC2 BCAN SIN3A KNDC1 SMO PADI2 MYO16 SEZ6L HTT	2.03e-07	859	250	30	GO:0007420
GeneOntologyBiologicalProcess	head development	STK36 MYH3 ABL1 ABL2 COQ8B SHROOM4 KIRREL3 MRTFB NFIX SEC24B AFDN TACC1 DNAH5 PLXNA1 SOX6 FLNA FAT4 MCPH1 DYNC2H1 RTN4 DUOX2 CHD8 TACC2 BCAN SIN3A KNDC1 SMO PADI2 MYO16 SEZ6L HTT	2.67e-07	919	250	31	GO:0060322
GeneOntologyBiologicalProcess	neuron projection development	ABL1 ABL2 MYCBP2 DAB2 LGR4 CHAT ADGRV1 CUL7 ITPR1 KIRREL3 MRTFB HMCN2 SNAP91 NFATC4 PTPRZ1 NFIX SEC24B AFDN PLD2 PREX1 PLXNA1 FLNA LRP12 FAT4 ANK3 ATCAY RTN4 BCAN SIN3A NR3C1 SHOC2 CELSR3 KNDC1 TRPV4 SMO AGRN MYO16 LGI1	3.05e-07	1285	250	38	GO:0031175
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	KIRREL3 FAT1 HMCN2 PIK3CB FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	4.94e-07	187	250	13	GO:0007156
GeneOntologyBiologicalProcess	cell morphogenesis	ABL1 ABL2 MYCBP2 SPTA1 DAB2 LGR4 CUL7 BRWD3 ITPR1 SHROOM4 KIRREL3 FAT1 HEG1 HMCN2 SNAP91 NFATC4 PTPRZ1 NFIX SEC24B CDC42EP2 AFDN PLXNA1 SOX6 FLNA ANK3 RTN4 BCAN SIN3A CELSR3 KNDC1 SMO AGRN MYO16 CDH15 LGI1	1.16e-06	1194	250	35	GO:0000902
GeneOntologyBiologicalProcess	central nervous system development	STK36 ABL1 ABL2 MYCBP2 COQ8B SHROOM4 KIRREL3 MRTFB PTPRZ1 NFIX SEC24B AFDN TACC1 DNAH5 ALDH5A1 PLXNA1 SOX6 FLNA FAT4 MCPH1 DYNC2H1 RTN4 DUOX2 CHD8 TACC2 BCAN SIN3A NR3C1 KNDC1 SMO PADI2 MYO16 SEZ6L HTT	3.35e-06	1197	250	34	GO:0007417
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	STK36 ABL1 CUL7 CEP68 CCDC66 ATXN3 TACC1 DNAH5 DYNC1H1 FLNA ANK3 MCPH1 TACC2 CEP192 CDC14A RP1L1 DNAH17 DNAI2 TRPV4 CFAP69 AGRN HTT CFAP46	2.43e-05	720	250	23	GO:0000226
GeneOntologyBiologicalProcess	forebrain development	KIRREL3 MRTFB NFIX AFDN TACC1 DNAH5 PLXNA1 FLNA FAT4 MCPH1 DYNC2H1 RTN4 DUOX2 TACC2 BCAN SIN3A SMO HTT	3.16e-05	489	250	18	GO:0030900
GeneOntologyBiologicalProcess	microtubule-based process	STK36 ABL1 CUL7 LYST CEP68 CCDC66 ATXN3 TACC1 RAB1A DNAH5 DYNC1H1 FLNA ANK3 MCPH1 DYNC2H1 TACC2 RHOT2 CEP192 CFAP298 CDC14A RP1L1 DNAH17 DNAI2 TRPV4 CFAP69 AGRN HTT CFAP46 DNAH11	3.60e-05	1058	250	29	GO:0007017
GeneOntologyBiologicalProcess	neuronal ion channel clustering	KCNB1 MTCH1 ANK3 AGRN	4.43e-05	17	250	4	GO:0045161
GeneOntologyBiologicalProcess	cerebral cortex development	NFIX AFDN TACC1 FLNA FAT4 MCPH1 RTN4 TACC2 SMO	7.87e-05	147	250	9	GO:0021987
GeneOntologyBiologicalProcess	cerebellum morphogenesis	ABL1 ABL2 COQ8B NFIX KNDC1 SMO	8.65e-05	60	250	6	GO:0021587
GeneOntologyBiologicalProcess	pallium development	KIRREL3 NFIX AFDN TACC1 FLNA FAT4 MCPH1 RTN4 TACC2 BCAN SMO	8.86e-05	222	250	11	GO:0021543
GeneOntologyBiologicalProcess	metencephalon development	ABL1 ABL2 COQ8B NFIX SEC24B KNDC1 SMO MYO16 SEZ6L	1.07e-04	153	250	9	GO:0022037
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	ABCA1 DENND4A ABL1 ABL2 ARHGEF11 RGL1 HEG1 PIK3CB NFIX CDC42EP2 PLD2 PREX1 RTN4 RHOT2 SHOC2 ARRB1 KNDC1 AGRN	1.07e-04	538	250	18	GO:0007264
GeneOntologyBiologicalProcess	regulation of clathrin-dependent endocytosis	DAB2 SNAP91 PROM2 PIK3CB	1.07e-04	21	250	4	GO:2000369
GeneOntologyBiologicalProcess	cilium assembly	STK36 TBC1D2 CCDC66 RAB1A DNAH5 FLNA DYNC2H1 CFAP298 CDC14A CELSR3 RP1L1 DNAH17 DNAI2 CFAP69 HTT CFAP46	1.12e-04	444	250	16	GO:0060271
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	KIRREL3 FAT1 HMCN2 PIK3CB FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	1.24e-04	313	250	13	GO:0098742
GeneOntologyBiologicalProcess	hindbrain morphogenesis	ABL1 ABL2 COQ8B NFIX KNDC1 SMO	1.24e-04	64	250	6	GO:0021575
GeneOntologyBiologicalProcess	neuron projection morphogenesis	ABL1 ABL2 MYCBP2 LGR4 CUL7 KIRREL3 HMCN2 SNAP91 NFATC4 PTPRZ1 NFIX AFDN PLXNA1 ANK3 RTN4 BCAN SIN3A CELSR3 KNDC1 SMO AGRN MYO16 LGI1	1.25e-04	802	250	23	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	ABL1 ABL2 MYCBP2 LGR4 CUL7 KIRREL3 HMCN2 SNAP91 NFATC4 PTPRZ1 NFIX AFDN PLXNA1 ANK3 RTN4 BCAN SIN3A CELSR3 KNDC1 SMO AGRN MYO16 LGI1	1.69e-04	819	250	23	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	ABL1 ABL2 MYCBP2 LGR4 CUL7 KIRREL3 HMCN2 SNAP91 NFATC4 PTPRZ1 NFIX AFDN PLXNA1 ANK3 RTN4 BCAN SIN3A CELSR3 KNDC1 SMO AGRN MYO16 LGI1	1.91e-04	826	250	23	GO:0048858
GeneOntologyBiologicalProcess	positive regulation of Wnt signaling pathway, planar cell polarity pathway	ABL1 ABL2 DAB2	1.98e-04	10	250	3	GO:2000096
GeneOntologyBiologicalProcess	monoubiquitinated protein deubiquitination	ATXN3 USP7 USP16	1.98e-04	10	250	3	GO:0035520
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	STK36 ABL1 ABL2 TBC1D2 CCDC66 CDC42EP2 RAB1A DNAH5 FLNA DYNC2H1 CFAP298 CDC14A CELSR3 RP1L1 DNAH17 DNAI2 CFAP69 AGRN HTT CFAP46	2.06e-04	670	250	20	GO:0120031
GeneOntologyBiologicalProcess	telencephalon development	KIRREL3 NFIX AFDN TACC1 DNAH5 FLNA FAT4 MCPH1 RTN4 TACC2 BCAN SMO HTT	2.21e-04	332	250	13	GO:0021537
GeneOntologyBiologicalProcess	positive regulation of substrate adhesion-dependent cell spreading	ABL1 DAB2 UNC13D PREX1 FLNA	2.30e-04	46	250	5	GO:1900026
GeneOntologyBiologicalProcess	hindbrain development	ABL1 ABL2 COQ8B NFIX SEC24B FLNA KNDC1 SMO MYO16 SEZ6L	2.36e-04	208	250	10	GO:0030902
GeneOntologyBiologicalProcess	cilium organization	STK36 TBC1D2 CCDC66 RAB1A DNAH5 FLNA DYNC2H1 CFAP298 CDC14A CELSR3 RP1L1 DNAH17 DNAI2 CFAP69 HTT CFAP46	2.46e-04	476	250	16	GO:0044782
GeneOntologyBiologicalProcess	cell projection assembly	STK36 ABL1 ABL2 TBC1D2 CCDC66 CDC42EP2 RAB1A DNAH5 FLNA DYNC2H1 CFAP298 CDC14A CELSR3 RP1L1 DNAH17 DNAI2 CFAP69 AGRN HTT CFAP46	2.75e-04	685	250	20	GO:0030031
GeneOntologyBiologicalProcess	cerebellum development	ABL1 ABL2 COQ8B NFIX KNDC1 SMO MYO16 SEZ6L	2.99e-04	139	250	8	GO:0021549
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	ABL1 ABL2 MYCBP2 LGR4 CUL7 HMCN2 SNAP91 NFATC4 PTPRZ1 NFIX SEC24B AFDN PLXNA1 ANK3 RTN4 SIN3A CELSR3 KNDC1 SMO AGRN LGI1	3.27e-04	748	250	21	GO:0048667
GeneOntologyBiologicalProcess	axoneme assembly	STK36 DNAH5 RP1L1 DNAH17 DNAI2 CFAP69 CFAP46	3.68e-04	109	250	7	GO:0035082
GeneOntologyBiologicalProcess	microtubule bundle formation	STK36 CCDC66 DNAH5 RP1L1 DNAH17 DNAI2 CFAP69 CFAP46	3.98e-04	145	250	8	GO:0001578
GeneOntologyCellularComponent	dynein complex	DNAH5 DYNC1H1 DYNC2H1 DNAH17 DNAI2 DNAH11	4.40e-05	54	250	6	GO:0030286
GeneOntologyCellularComponent	somatodendritic compartment	ABL1 ABL2 CHAT KCNB2 ITPR1 PPARGC1A KIRREL3 HMCN2 KCNB1 SNAP91 PTPRZ1 AFDN GRIN3B RAB1A PREX1 DYNC1H1 HSP90AA4P MPP2 FLNA ANK3 ATCAY RTN4 CNKSR2 BCAN NR3C1 ARRB1 KNDC1 SMO SEZ6L HTT LGI1	6.96e-05	1228	250	31	GO:0036477
MousePheno	perinatal lethality	SP3 TRAF2 ABCA1 ABL1 KMT2B MYCBP2 RC3H1 SPTA1 RPS7 LGR4 MCM3 CHAT CUL7 FAT1 EHBP1L1 MRTFB SCNN1A DNAH5 UNC79 DYNC1H1 BAHCC1 SOX6 SIN3B FAT4 EVC2 ANK2 MCPH1 RIPK4 NR3C1 LGR5 CELSR3 NEK8 AGRN UNC80 HTT DNAH11 MAF	6.27e-06	1130	212	37	MP:0002081
Domain	Cadherin_CS	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	1.85e-06	109	247	10	IPR020894
Domain	DHC_N1	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.00e-06	8	247	4	PF08385
Domain	Dynein_heavy_dom-1	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.00e-06	8	247	4	IPR013594
Domain	CADHERIN_1	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	2.57e-06	113	247	10	PS00232
Domain	Cadherin	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	2.57e-06	113	247	10	PF00028
Domain	-	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	2.78e-06	114	247	10	2.60.40.60
Domain	CADHERIN_2	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	2.78e-06	114	247	10	PS50268
Domain	CA	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	3.02e-06	115	247	10	SM00112
Domain	Cadherin-like	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	3.26e-06	116	247	10	IPR015919
Domain	Cadherin	FAT1 FAT4 PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7 CDH15	3.81e-06	118	247	10	IPR002126
Domain	ATPase_dyneun-rel_AAA	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	IPR011704
Domain	MT	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	PF12777
Domain	AAA_8	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	PF12780
Domain	AAA_5	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	PF07728
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	IPR013602
Domain	DHC_N2	DNAH5 DYNC1H1 DYNC2H1 DNAH11	2.69e-05	14	247	4	PF08393
Domain	DHC_fam	DNAH5 DYNC1H1 DYNC2H1 DNAH11	3.63e-05	15	247	4	IPR026983
Domain	Dynein_heavy	DNAH5 DYNC1H1 DYNC2H1 DNAH11	3.63e-05	15	247	4	PF03028
Domain	Dynein_heavy_dom	DNAH5 DYNC1H1 DYNC2H1 DNAH11	3.63e-05	15	247	4	IPR004273
Domain	BRK	CHD6 CHD9 CHD8	4.44e-05	6	247	3	SM00592
Domain	BRK_domain	CHD6 CHD9 CHD8	4.44e-05	6	247	3	IPR006576
Domain	BRK	CHD6 CHD9 CHD8	4.44e-05	6	247	3	PF07533
Domain	LRR_1	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 LRRC41 FLII SHOC2 LGR5 LRRCC1 LGI1	1.67e-04	219	247	11	PF00560
Domain	Sin3_C	SIN3B SIN3A	1.74e-04	2	247	2	IPR031693
Domain	F_actin_bind	ABL1 ABL2	1.74e-04	2	247	2	PF08919
Domain	K_chnl_volt-dep_Kv2	KCNB2 KCNB1	1.74e-04	2	247	2	IPR003973
Domain	Sin3_corepress	SIN3B SIN3A	1.74e-04	2	247	2	PF08295
Domain	FABD	ABL1 ABL2	1.74e-04	2	247	2	SM00808
Domain	HDAC_interact	SIN3B SIN3A	1.74e-04	2	247	2	SM00761
Domain	F-actin_binding	ABL1 ABL2	1.74e-04	2	247	2	IPR015015
Domain	ATG2	ATG2A ATG2B	1.74e-04	2	247	2	IPR026849
Domain	Sin3a_C	SIN3B SIN3A	1.74e-04	2	247	2	PF16879
Domain	HDAC_interact_dom	SIN3B SIN3A	1.74e-04	2	247	2	IPR013194
Domain	Kv2channel	KCNB2 KCNB1	1.74e-04	2	247	2	PF03521
Domain	ATG2_CAD	ATG2A ATG2B	1.74e-04	2	247	2	PF13329
Domain	ATG2_CAD_motif	ATG2A ATG2B	1.74e-04	2	247	2	IPR026885
Domain	Cadherin_2	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12 PCDH7	2.17e-04	65	247	6	PF08266
Domain	Cadherin_N	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12 PCDH7	2.17e-04	65	247	6	IPR013164
Domain	Cadherin_C	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12	2.22e-04	42	247	5	IPR032455
Domain	Cadherin_C_2	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12	2.22e-04	42	247	5	PF16492
Domain	Leu-rich_rpt_4	PODNL1 LRRIQ4 FLII	2.56e-04	10	247	3	IPR025875
Domain	LRR_4	PODNL1 LRRIQ4 FLII	2.56e-04	10	247	3	PF12799
Domain	-	ADGRV1 FAT1 FAT4 COL11A2 ADGRG6 CELSR3 AGRN	2.67e-04	95	247	7	2.60.120.200
Domain	LamG	FAT1 FAT4 COL11A2 CELSR3 AGRN	2.77e-04	44	247	5	SM00282
Domain	EGF_3	ADAM20 MEP1B FAT1 HEG1 FBLN2 HMCN2 FAT4 BCAN MALRD1 CELSR3 AGRN	3.07e-04	235	247	11	PS50026
Domain	MATH	TRAF2 MEP1B USP7	4.60e-04	12	247	3	PS50144
Domain	MATH	TRAF2 MEP1B USP7	4.60e-04	12	247	3	SM00061
Domain	MATH/TRAF_dom	TRAF2 MEP1B USP7	4.60e-04	12	247	3	IPR002083
Domain	MATH	TRAF2 MEP1B USP7	4.60e-04	12	247	3	PF00917
Domain	EGF-like_dom	ADAM20 MEP1B FAT1 HEG1 FBLN2 HMCN2 FAT4 BCAN MALRD1 CELSR3 AGRN	5.01e-04	249	247	11	IPR000742
Domain	PAH	SIN3B SIN3A	5.18e-04	3	247	2	PS51477
Domain	TACC	TACC1 TACC2	5.18e-04	3	247	2	PF05010
Domain	PAH	SIN3B SIN3A	5.18e-04	3	247	2	IPR003822
Domain	-	SIN3B SIN3A	5.18e-04	3	247	2	1.20.1160.11
Domain	PAH	SIN3B SIN3A	5.18e-04	3	247	2	PF02671
Domain	TACC	TACC1 TACC2	5.18e-04	3	247	2	IPR007707
Domain	Leu-rich_rpt_typical-subtyp	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 FLII SHOC2 LGR5 LGI1	5.96e-04	177	247	9	IPR003591
Domain	LRR_TYP	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 FLII SHOC2 LGR5 LGI1	5.96e-04	177	247	9	SM00369
Domain	-	LRP12 CDCP1 ADGRG6 CSMD1 SEZ6L	6.08e-04	52	247	5	2.60.120.290
Domain	EGF_1	ADAM20 MEP1B FAT1 HEG1 FBLN2 HMCN2 FAT4 BCAN MALRD1 CELSR3 AGRN	6.11e-04	255	247	11	PS00022
Domain	CUB	LRP12 CDCP1 ADGRG6 CSMD1 SEZ6L	6.64e-04	53	247	5	PS01180
Domain	EGF-like_CS	ADAM20 MEP1B FAT1 HEG1 FBLN2 HMCN2 FAT4 BCAN MALRD1 CELSR3 AGRN	7.40e-04	261	247	11	IPR013032
Domain	EGF_2	ADAM20 MEP1B FAT1 HEG1 FBLN2 HMCN2 FAT4 BCAN MALRD1 CELSR3 AGRN	8.38e-04	265	247	11	PS01186
Domain	CUB_dom	LRP12 CDCP1 ADGRG6 CSMD1 SEZ6L	9.29e-04	57	247	5	IPR000859
Domain	Leu-rich_rpt	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 LRRC41 FLII SHOC2 LGR5 LRRCC1 LGI1	1.01e-03	271	247	11	IPR001611
Domain	Laminin_G	FAT1 FAT4 COL11A2 CELSR3 AGRN	1.01e-03	58	247	5	IPR001791
Domain	OAS1_C	OAS2 OAS3	1.03e-03	4	247	2	PF10421
Domain	25A_SYNTH_3	OAS2 OAS3	1.03e-03	4	247	2	PS50152
Domain	2-5A_synthase	OAS2 OAS3	1.03e-03	4	247	2	IPR026774
Domain	-	OAS2 OAS3	1.03e-03	4	247	2	1.10.1410.20
Domain	2-5-oligoadenylate_synth_CS	OAS2 OAS3	1.03e-03	4	247	2	IPR006117
Domain	2-5-oligoAdlate_synth_1_dom2/C	OAS2 OAS3	1.03e-03	4	247	2	IPR018952
Domain	25A_SYNTH_1	OAS2 OAS3	1.03e-03	4	247	2	PS00832
Domain	25A_SYNTH_2	OAS2 OAS3	1.03e-03	4	247	2	PS00833
Domain	EGF_CA	FAT1 HEG1 FBLN2 HMCN2 FAT4 CELSR3 AGRN	1.20e-03	122	247	7	SM00179
Domain	-	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 LRRC41 FLII SHOC2 LGR5 CMIP LRRCC1 LGI1	1.22e-03	321	247	12	3.80.10.10
Domain	EGF-like_Ca-bd_dom	FAT1 HEG1 FBLN2 HMCN2 FAT4 CELSR3 AGRN	1.32e-03	124	247	7	IPR001881
Domain	Cadherin_tail	PCDHGB3 PCDHGA10 PCDHGA9 PCDHGA12	1.40e-03	37	247	4	PF15974
Domain	Cadherin_CBD	PCDHGB3 PCDHGA10 PCDHGA9 PCDHGA12	1.40e-03	37	247	4	IPR031904
Domain	EGF	MEP1B FAT1 HEG1 BCAN MALRD1 CELSR3 AGRN	1.45e-03	126	247	7	PF00008
Domain	LRR	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 FLII SHOC2 LGR5 LRRCC1	1.46e-03	201	247	9	PS51450
Domain	L_dom-like	PODNL1 LRRC49 LGR4 LRRIQ4 RXFP2 LRRC41 FLII SHOC2 LGR5 CMIP LRRCC1 LGI1	1.47e-03	328	247	12	IPR032675
Domain	LAM_G_DOMAIN	FAT1 FAT4 CELSR3 AGRN	1.55e-03	38	247	4	PS50025
Domain	PH_dom-like	TBC1D2 DAB2 ARHGEF11 LYST PTPN13 OSBPL11 PLD2 PREX1 NSMAF ASAP3 CNKSR2 PLEKHG2 CMIP GAB1	1.68e-03	426	247	14	IPR011993
Domain	UbiB_dom	COQ8B ADCK1	1.70e-03	5	247	2	IPR004147
Domain	PAD_N	PADI1 PADI2	1.70e-03	5	247	2	PF08526
Domain	PAD_M	PADI1 PADI2	1.70e-03	5	247	2	PF08527
Domain	Prot_Arg_deaminase_cen_dom	PADI1 PADI2	1.70e-03	5	247	2	IPR013733
Domain	PAD_N	PADI1 PADI2	1.70e-03	5	247	2	IPR013732
Domain	KIND	PTPN13 KNDC1	1.70e-03	5	247	2	PS51377
Domain	KIND_dom	PTPN13 KNDC1	1.70e-03	5	247	2	IPR011019
Domain	KIND	PTPN13 KNDC1	1.70e-03	5	247	2	SM00750
Domain	2-5-oligoadenylate_synth_N	OAS2 OAS3	1.70e-03	5	247	2	IPR006116
Domain	PAD	PADI1 PADI2	1.70e-03	5	247	2	PF03068
Domain	PAD	PADI1 PADI2	1.70e-03	5	247	2	IPR004303
Domain	Autophagy-rel_C	ATG2A ATG2B	1.70e-03	5	247	2	IPR015412
Domain	ATG_C	ATG2A ATG2B	1.70e-03	5	247	2	PF09333
Domain	PAD_C	PADI1 PADI2	1.70e-03	5	247	2	IPR013530
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	STK36 ABL1 KMT2B MYCBP2 ATG2A ARHGEF11 LYST FAT1 EHBP1L1 HEG1 PNPLA6 UBN1 PROM2 USP7 C19orf44 PREX1 PLXNA1 DYNC1H1 BAHCC1 FLII FLNA RNPEPL1 NSD1 AMBRA1 CHD8 RHOT2 CEP192 REV3L C8orf58 CELSR3 NEK8 DHX34 AGRN HTT	1.94e-12	1105	255	34	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TRAF2 COQ8B LGR4 CUL7 BRWD3 FAT1 PNPLA6 HMCN2 ZC3H4 TMEM59L ZBTB21 USP7 MGA LRRC41 ARMC6 BAHCC1 AMBRA1 CHD9 OAS3 CHD8 RHOT2 SIN3A REV3L RAB11FIP1 MLH3 LTN1 ELF3 CSMD1 PADI2 DHX34 UNC80 CDH15 SLC4A11 SEZ6L	2.55e-12	1116	255	34	31753913
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAPVD1 KMT2B MYCBP2 MCM3 ADAR PTPN13 MRTFB SEC24B USP7 OSBPL11 AFDN MGA DYNC1H1 DNMT1 FLNA SIN3B ANK3 ATG2B CAST NSD1 CHD8 SIN3A HTT	2.41e-11	549	255	23	38280479
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	EPS15 GAPVD1 LEMD3 RPS7 LGR4 MCM3 FAT1 PTPN13 ZC3H4 SEC24B CDC42EP2 AFDN TACC1 MGA DYNC1H1 DNMT1 FAT4 ANK3 DNAJC16 ANKRD26 BSDC1 CNKSR2 CEP192 IGF2BP3 PCDH7 GAB1 ATP5F1C	2.95e-11	777	255	27	35844135
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TRAF2 MYCBP2 BRWD3 UBA7 PTPN13 USP7 AFDN MIGA1 CHD6 WDR17 ALDH5A1 PREX1 CNOT2 DYNC1H1 DNMT1 SOX6 FLII ANK2 ANK3 CHD9 RIPK4 REV3L USP16 CFAP298 TDP2 TARS3 ARRB1 CELSR3 SBNO1 CIAO3 LRRCC1 PADI2 SEZ6L LGI1	1.12e-10	1285	255	34	35914814
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	STK36 EPS15 SP3 AFTPH DAB2 ATG2A MRTFB UBN1 NFATC4 TMEM59L USP7 MGA DYNC1H1 ANK3 ASAP3 CNKSR2 SIN3A GAB1	3.87e-09	430	255	18	35044719
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ABL1 ABL2 TBC1D2 ADAR FAT1 UBN1 ZC3H4 TACC1 DNAH5 DYNC1H1 DNMT1 FLNA NSD1 CHD8 FAM131A CDCP1	4.01e-09	332	255	16	37433992
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	EPS15 ABL1 ABL2 KMT2B DAB2 CUL7 KCNB2 ARHGEF11 SEC24B FLNA ANK2 RTN4 CAST CELSR3 NEK8	2.59e-08	329	255	15	17474147
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPS15 GAPVD1 AFTPH ADAR PTPN13 MRTFB ZC3H4 SEC24B ZBTB21 USP7 OSBPL11 TACC1 DNMT1 FLNA SIN3B ANK2 RTN4 ATG2B CAST ANKRD26 TACC2 SIN3A NR3C1 USP16 IGF2BP3	3.12e-08	934	255	25	33916271
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH5 DYNC1H1 DYNC2H1 DNAH17 DNAH11	3.86e-08	14	255	5	9373155
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GAPVD1 AFTPH KMT2B MYCBP2 TBC1D2 DAB2 MCM3 WWC2 PNPLA6 UBN1 ZC3H4 ZBTB21 USP7 OSBPL11 AFDN DNMT1 FLII FLNA CAST SIN3A USP16 PCDH7	7.80e-08	774	255	22	15302935
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MYCBP2 RPS7 KCNB2 ITPR1 KCNB1 USP7 AFDN TACC1 ALDH5A1 MTCH1 CNOT2 ARMC6 MPP2 FLII FLNA ANK2 ANK3 DNAJC16 RTN4 ADCK1 ATG2B BSDC1 ANXA8 CNKSR2 TACC2 SHOC2 KNDC1	1.01e-07	1139	255	27	36417873
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STK36 RC3H1 CUL7 SHROOM4 CEP68 RGL1 MGA PREX1 SIN3B DYNC2H1 ANKRD26 ZNF407 CMIP DNAH17 LTN1 LRRCC1 UNC80	1.73e-07	493	255	17	15368895
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	EPS15 MYCBP2 MCM3 ARHGEF11 KCNB1 SNAP91 ZC3H4 ZBTB21 AFDN MGA RAB1A UNC79 DYNC1H1 DNMT1 MPP2 FLII SIN3B ANK2 ANK3 NSD1 CHD8 CNKSR2 AGRN LGI1	2.20e-07	963	255	24	28671696
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DENND4A ITPR1 ZC3H4 OSBPL11 AFDN RAB1A LRRC41 DNMT1 DNAJC16 RTN4 AMBRA1 CHD8 SIN3A NR3C1 AACS DBR1 DHX34 AGRN ATP5F1C	4.07e-07	650	255	19	38777146
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GAPVD1 ABL2 AFTPH RPS7 MCM3 ATG2A ARHGEF11 CCDC66 MRTFB SEC24B AFDN MGA DYNC1H1 IPO8 CAST ANKRD26 BSDC1 CEP192 PLEKHG2 PPM1F LRRCC1 AGRN	4.07e-07	853	255	22	28718761
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GAPVD1 DENND4A ABL1 ABL2 AFTPH MYCBP2 RPS7 LYST WWC2 PTPN13 SEC24B ZBTB21 AFDN DNMT1 ANKRD26 CEP192 PLEKHG2 RAB11FIP1 CDC14A IKBKE PCDH7 GAB1	4.76e-07	861	255	22	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EPS15 GAPVD1 KMT2B MYCBP2 LRRC49 PTPN13 MRTFB ZBTB21 CHD6 MGA FLNA SIN3B ATG2B CHD8 PPM1F	5.65e-07	418	255	15	34709266
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	EPS15 GAPVD1 LEMD3 C17orf75 MRTFB SEC24B OSBPL11 AFDN TACC1 FLNA ANK2 RTN4 BSDC1 TDP2 ATP5F1C	1.38e-06	449	255	15	31732153
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12 PCDH7	2.11e-06	80	255	7	10716726
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TRAF2 MYCBP2 RPS7 MCM3 SUCLG2 ADAR PNPLA6 FBXL18 UBN1 SEC24B USP7 AFDN MGA DYNC1H1 DNMT1 FLII FLNA AMBRA1 OAS3 CHD8 RHOT2 USP16 PPM1F LTN1 DHX34 AGRN ATP5F1C	2.77e-06	1353	255	27	29467282
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	MYH3 SPTA1 ADGRV1 ADCK1 ANKRD26 BSDC1 CSMD1	2.94e-06	84	255	7	15203218
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH3 DENND4A SPTA1 RPS7 LYST SNAP91 FAM186A ZBTB21 CHD6 RAB1A PREX1 BAHCC1 FLNA ANK2 PCDHGB3 PCDHGA10 PCDHGA9 ANKRD26 HKDC1 DUOX2 ARRB1 SBNO1 PCDHGA12 CIAO3 CFAP69 SLC4A11 CFAP46 ATP5F1C	3.01e-06	1442	255	28	35575683
Pubmed	A gene-targeting approach for functional characterization of KIAA genes encoding extremely large proteins.	UNC79 BAHCC1 KNDC1	3.85e-06	5	255	3	16807365
Pubmed	Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair.	LYST FOXN1 SMO	3.85e-06	5	255	3	20971735
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	LEMD3 RPS7 MRTFB LPCAT2 AFDN TACC1 FLNA SIN3B DNAJC16 RTN4 USP16 IGF2BP3 ATP5F1C	4.71e-06	375	255	13	32788342
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EPS15 MYCBP2 ADGRV1 BRWD3 PTPN13 MRTFB PNPLA6 PROM2 NFIX SCNN1A CHD6 NSMAF LRRC41 ANK3 MCPH1 UVSSA CAST CHD9 CEP192 ADGRG6 CMIP ARRB1 KNDC1 CSMD1 CFAP69 CDH15 HTT MAF	5.50e-06	1489	255	28	28611215
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	LEMD3 FAT1 EHBP1L1 PROM2 CDC42EP2 RAB1A PLXNA1 ANK2 DNAJC16 SLC43A1 ASAP3 ANKRD26 RAB11FIP1 CDCP1 PCDH7 GAB1	5.57e-06	569	255	16	30639242
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	DENND4A LEMD3 ATG2A LYST ITPR1 PTPN13 SEC24B OSBPL11 MIGA1 TACC1 PLXNA1 DNAJC16 RTN4 ATG2B PCDH7	5.59e-06	504	255	15	34432599
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 ADGRV1 CEP68 MRTFB ZC3H4 CHD6 PREX1 DNAJC16 CHD8 UNC80	7.10e-06	225	255	10	12168954
Pubmed	Human transcription factor protein interaction networks.	KMT2B RC3H1 LRRC49 CUL7 FAT1 UBN1 NFATC4 NFIX SEC24B ZBTB21 USP7 CHD6 MGA RAB1A CNOT2 DYNC1H1 SOX6 SIN3B CHD8 RHOT2 CEP192 SIN3A TDP2 IGF2BP3 ELF3 PCDH7 ATP5F1C	7.50e-06	1429	255	27	35140242
Pubmed	Functional proteomics mapping of a human signaling pathway.	EPS15 KMT2B MYCBP2 LEMD3 DAB2 MRTFB AFDN CHD6 MGA DYNC1H1 FLNA EVC2 ANK3 RHOT2 TDP2 PHACTR3	8.93e-06	591	255	16	15231748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GAPVD1 ATG2A ADGRV1 ZC3H4 ZBTB21 RAB1A UVSSA RTN4 AMBRA1 CHD8 SHOC2 CELSR3 PPM1F PADI2 DHX34	9.93e-06	529	255	15	14621295
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	SUCLG2 ITPR1 PTPN13 PNPLA6 ARMC6 LTN1 HTT	1.22e-05	104	255	7	31240132
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH5 DNAH17 DNAH11	1.33e-05	7	255	3	31178125
Pubmed	Humanized mice in translational biomedical research.	LYST FOXN1 MCPH1	1.33e-05	7	255	3	17259968
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	STK36 PLB1 GLYCTK ITPR1 SEC24B USP7 CHD6 MGA DYNC1H1 FLII FLNA FAT4 IPO8 DYNC2H1 RAB11FIP1 ESYT3 IGF2BP3 ATP5F1C	1.35e-05	754	255	18	35906200
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 CELSR3 PCDHGA12	1.53e-05	72	255	6	10380929
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	LYST ITPR1 SHROOM4 FAT1 COL7A1 IPO8 DUOX2 ESYT3 DBR1 DHX34 TINCR UNC80 ZNF639 ATP5F1C DNAH11	1.63e-05	552	255	15	10737800
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EPS15 SP3 AFTPH KMT2B LEMD3 SLC39A11 WDR55 ARHGEF11 PTPN13 MRTFB PNPLA6 SEC24B USP7 AFDN CHD6 PREX1 CNOT2 SIN3B DNAJC16 PCDHB7 NSD1 CHD8 RAB11FIP1 ARRB1 LTN1 AGRN ATP5F1C	1.71e-05	1497	255	27	31527615
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ABCA1 ABL1 LGR4 ITPR1 RGL1 SNAP91 ZC3H4 CHD6 MGA FLNA NR3C1 SMO	1.76e-05	363	255	12	14691545
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	ANKRD31 PODNL1 ADGRV1 ADAR REV3L AGRN HTT DNAH11	1.77e-05	152	255	8	34299191
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12 PCDH7	1.79e-05	74	255	6	10817752
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GAPVD1 LGR4 UNC13D ITPR1 PPARGC1A WWC2 PTPN13 RXFP2 OSBPL11 MGA CNOT2 SERTAD3 FLNA ANK3 CAST NSD1 TACC2 RHOT2 CEP192 CDCP1 LTN1 AGRN	1.88e-05	1084	255	22	11544199
Pubmed	A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-alpha treatment in chronic hepatitis B patients.	ADAR OAS2 OAS3	2.12e-05	8	255	3	19559055
Pubmed	Interplay between polypyrimidine tract binding protein-associated splicing factor and human myometrial progesterone receptors.	SP3 SIN3A NR3C1	2.12e-05	8	255	3	19339282
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	EPS15 GAPVD1 ABL2 RPS7 MCM3 PTPN13 SEC24B AFDN DYNC1H1 ANK2 ANK3 RTN4 ATG2B ANKRD26 PCDH7 GAB1 ATP5F1C	2.19e-05	708	255	17	39231216
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12 PCDH7	2.25e-05	77	255	6	10835267
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TRAF2 EHBP1L1 C17orf75 MED22 CHD6 WDR17 PREX1 LRRC41 FAT4 DYNC2H1 RHOT2 REV3L NR3C1 PPM1F PHACTR3 DNAH11	2.27e-05	638	255	16	31182584
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	GAPVD1 LEMD3 DAB2 ITPR1 MRTFB LPCAT2 SEC24B OSBPL11 TACC1 RAB1A FLNA RTN4 ATG2B CAST BSDC1	2.27e-05	568	255	15	37774976
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	GAPVD1 DENND4A AFTPH DAB2 PTPN13 ATG2B CEP192 IGF2BP3 GAB1	2.62e-05	209	255	9	36779422
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	EPS15 ABL2 DAB2 EHBP1L1 PTPN13 PNPLA6 STOML1 SEC24B CDC42EP2 OSBPL11 AFDN LRP12 IPO8 CNKSR2 CEP192 RAB11FIP1 AGRN	2.66e-05	719	255	17	35337019
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	GAPVD1 LEMD3 RPS7 KCNB2 PTPN13 SEC24B TACC1 SIN3B ANK3 ANKRD26	2.73e-05	263	255	10	34702444
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	EPS15 UBN1 SEC24B ZBTB21 USP7 MGA FLNA RTN4 CHD8 TACC2 NR3C1 TDP2 SBNO1	2.80e-05	444	255	13	34795231
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	EPS15 TRAF2 ABL1 ABL2 SPTA1 RPS7 PIK3CB DYNC1H1 ASAP3 GAB1	3.01e-05	266	255	10	19380743
Pubmed	Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.	DNAH5 EVC2 DYNC2H1 DNAH11	3.16e-05	25	255	4	27340223
Pubmed	Ellis-van Creveld Syndrome	EVC2 DYNC2H1 SMO	3.17e-05	9	255	3	37903214
Pubmed	Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.	ATXN3 CASP1 HTT	3.17e-05	9	255	3	9535906
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	RPS7 MCM3 CUL7 MRTFB UBN1 USP7 DYNC2H1 ANKRD26 TACC2 CEP192 AASDH NR3C1 TDP2 IGF2BP3 GAB1	3.38e-05	588	255	15	38580884
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYCBP2 LEMD3 RPS7 WDR55 CUL7 ITPR1 WWC2 PTPN13 PTPRZ1 SEC24B USP7 DNMT1 ANK3 CEP192 RAB11FIP1 SHOC2 CDC14A PPM1F LTN1 PCDH7 GAB1	3.55e-05	1049	255	21	27880917
Pubmed	ZMYND10 functions in a chaperone relay during axonemal dynein assembly.	DNAH5 DNAH17 DNAI2	4.50e-05	10	255	3	29916806
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	SPTA1 ANK2 ANK3	4.50e-05	10	255	3	22159418
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TRAF2 MYCBP2 LEMD3 LRRC49 COQ8B CUL7 SUCLG2 ITPR1 ZC3H4 SEC24B ATXN3 OSBPL11 MIGA1 TACC1 RAB1A ALDH5A1 MTCH1 FLII IPO8 OSTM1 RTN4 ATG2B TACC2 RHOT2 IGF2BP3 ATP5F1C	4.59e-05	1496	255	26	32877691
Pubmed	Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases.	ABL1 ABL2	5.35e-05	2	255	2	15987940
Pubmed	Atg2A/B deficiency switches cytoprotective autophagy to non-canonical caspase-8 activation and apoptosis.	ATG2A ATG2B	5.35e-05	2	255	2	28800131
Pubmed	Solution structures and backbone dynamics of arsenate reductase from Bacillus subtilis: reversible conformational switch associated with arsenate reduction.	ABCA1 ARHGEF11	5.35e-05	2	255	2	16192272
Pubmed	Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter.	CHAT AGRN	5.35e-05	2	255	2	16043708
Pubmed	Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway.	ABCA1 PLD2	5.35e-05	2	255	2	16118212
Pubmed	Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets.	ATG2A ATG2B	5.35e-05	2	255	2	22219374
Pubmed	The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection.	ABL1 ABL2	5.35e-05	2	255	2	22665498
Pubmed	Kv2 Ion Channels Determine the Expression and Localization of the Associated AMIGO-1 Cell Adhesion Molecule in Adult Brain Neurons.	KCNB2 KCNB1	5.35e-05	2	255	2	29403353
Pubmed	The expression of the non-receptor tyrosine kinases Arg and c-abl is differently modulated in B lymphoid cells at different stages of differentiation.	ABL1 ABL2	5.35e-05	2	255	2	12220663
Pubmed	Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B.	ITPR1 ANK2	5.35e-05	2	255	2	14722080
Pubmed	The Filamin-A is a partner of Tc-mip, a new adapter protein involved in c-maf-dependent Th2 signaling pathway.	FLNA CMIP	5.35e-05	2	255	2	15128042
Pubmed	Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.	PPARGC1A HTT	5.35e-05	2	255	2	17018277
Pubmed	Genetic resistance to murine cryptococcosis: the beige mutation (Chédiak-Higashi syndrome) in mice.	LYST FOXN1	5.35e-05	2	255	2	3965401
Pubmed	Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin.	ABL1 ABL2	5.35e-05	2	255	2	17686996
Pubmed	Genetic analysis of the cytoplasmic dynein subunit families.	DYNC1H1 DYNC2H1	5.35e-05	2	255	2	16440056
Pubmed	Remodeling neuronal ER-PM junctions is a conserved nonconducting function of Kv2 plasma membrane ion channels.	KCNB2 KCNB1	5.35e-05	2	255	2	30091655
Pubmed	Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region.	LGR4 LGR5	5.35e-05	2	255	2	9849958
Pubmed	Rare variants in dynein heavy chain genes in two individuals with situs inversus and developmental dyslexia: a case report.	DNAH5 DNAH11	5.35e-05	2	255	2	32357925
Pubmed	Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion.	PDCD1 PPARGC1A	5.35e-05	2	255	2	27496729
Pubmed	Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.	ABL1 ABL2	5.35e-05	2	255	2	20181697
Pubmed	Insights into Conformational Dynamics and Allostery in DNMT1-H3Ub/USP7 Interactions.	USP7 DNMT1	5.35e-05	2	255	2	34500587
Pubmed	Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors.	ABL1 GAB1	5.35e-05	2	255	2	32859628
Pubmed	Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita.	FLII COL7A1	5.35e-05	2	255	2	21984127
Pubmed	c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.	ABL1 ABL2	5.35e-05	2	255	2	20150913
Pubmed	Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation.	USP7 DNMT1	5.35e-05	2	255	2	25960197
Pubmed	Kv2 channels do not function as canonical delayed rectifiers in spinal motoneurons.	CHAT KCNB1	5.35e-05	2	255	2	39148717
Pubmed	Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon.	TACC1 TACC2	5.35e-05	2	255	2	10435627
Pubmed	Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases.	ABL1 ABL2	5.35e-05	2	255	2	28555614
Pubmed	Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.	ATXN3 HTT	5.35e-05	2	255	2	19492089
Pubmed	A comparison of UVB-carcinogenesis between nude mice and nude beige mice.	LYST FOXN1	5.35e-05	2	255	2	9735600
Pubmed	Loss of dendrite stabilization by the Abl-related gene (Arg) kinase regulates behavioral flexibility and sensitivity to cocaine.	ABL1 ABL2	5.35e-05	2	255	2	19805386
Pubmed	s-Afadin binds to MAGUIN/Cnksr2 and regulates the localization of the AMPA receptor and glutamatergic synaptic response in hippocampal neurons.	AFDN CNKSR2	5.35e-05	2	255	2	36803960
Pubmed	Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.	USP7 HTT	5.35e-05	2	255	2	33170804
Pubmed	LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.	DNMT1 TINCR	5.35e-05	2	255	2	33446634
Pubmed	Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion.	DYNC1H1 DYNC2H1	5.35e-05	2	255	2	25502651
Pubmed	Eps15 homology domain-NPF motif interactions regulate clathrin coat assembly during synaptic vesicle recycling.	EPS15 SNAP91	5.35e-05	2	255	2	12807910
Pubmed	BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.	ABL1 USP7	5.35e-05	2	255	2	24317448
Interaction	OTUD7A interactions	KCNB2 KCNB1 AFDN FLII ANK2 ANK3 KNDC1	8.30e-06	58	255	7	int:OTUD7A
Interaction	MEX3A interactions	ABL1 ABL2 RC3H1 TBC1D2 ADAR FAT1 UBN1 ZC3H4 TACC1 DNAH5 DYNC1H1 DNMT1 FLNA NSD1 CHD8 FAM131A CDCP1	8.69e-06	384	255	17	int:MEX3A
Interaction	UCN3 interactions	ADGRV1 FAT1 FAT4 HKDC1 PCDH7	8.71e-06	23	255	5	int:UCN3
Interaction	DKKL1 interactions	ADGRV1 FAT1 C17orf75 TMEM59L FAT4 RHOT2 CELSR3 LTN1 PCDH7	1.19e-05	111	255	9	int:DKKL1
Interaction	XAGE1A interactions	ADGRV1 FAT1 FAT4 CHD8 CELSR3 PCDH7	1.20e-05	41	255	6	int:XAGE1A
Interaction	PRSS37 interactions	ARSK ADGRV1 FAT1 FAT4	3.06e-05	15	255	4	int:PRSS37
Interaction	PHF21A interactions	EPS15 SP3 GAPVD1 KMT2B MYCBP2 LRRC49 PTPN13 MRTFB CHD6 MGA FLNA SIN3B ATG2B CHD8 PPM1F	3.40e-05	343	255	15	int:PHF21A
Interaction	YWHAQ interactions	DENND4A ABL1 ABL2 AFTPH MYCBP2 RC3H1 SPTA1 MCM3 CHAT CUL7 LYST WWC2 PTPN13 NFATC4 PIK3CB ZBTB21 AFDN UNC79 DYNC1H1 DNMT1 FLNA ANKRD26 CEP192 RIPK4 RAB11FIP1 CDC14A IGF2BP3 ARRB1 PCDH7 GAB1 HTT	3.49e-05	1118	255	31	int:YWHAQ
Interaction	TOP3B interactions	STK36 ABL1 KMT2B MYCBP2 ATG2A ARHGEF11 LYST FAT1 EHBP1L1 HEG1 PNPLA6 UBN1 PROM2 SEC24B USP7 C19orf44 PREX1 CNOT2 PLXNA1 DYNC1H1 BAHCC1 FLII FLNA RNPEPL1 NSD1 AMBRA1 CHD8 RHOT2 CEP192 REV3L CDC14A C8orf58 CELSR3 NEK8 DHX34 AGRN HTT	4.66e-05	1470	255	37	int:TOP3B
Interaction	PCDHGB1 interactions	LEMD3 FAT4 PCDHGB3 PCDHGA9 CELSR3 PCDHGA12 PCDH7	5.41e-05	77	255	7	int:PCDHGB1
Interaction	PRKCD interactions	DAB2 CHAT ITPR1 MEP1B PIK3CB PLD2 MTCH1 DYNC1H1 CHD9 RIPK4 CDCP1 HTT	5.42e-05	238	255	12	int:PRKCD
Interaction	NXPH2 interactions	ADGRV1 FAT1 FAT4 RHOT2 PCDH7	5.54e-05	33	255	5	int:NXPH2
Interaction	YAP1 interactions	TRAF2 GAPVD1 ABL1 KMT2B RPS7 MCM3 ADAR WWC2 PTPN13 MRTFB TMEM59L ATXN3 USP7 AFDN MGA RAB1A DYNC1H1 DNMT1 HSP90AA4P FLNA SIN3B ANK3 RTN4 CAST NSD1 CHD8 CNKSR2 SIN3A IKBKE GAB1	5.85e-05	1095	255	30	int:YAP1
GeneFamily	Dyneins, axonemal	DNAH5 DNAH17 DNAI2 DNAH11	1.79e-05	17	174	4	536
GeneFamily	Clustered protocadherins	PCDHGB3 PCDHGA10 PCDHGA9 PCDHB7 PCDHGA12	3.76e-04	64	174	5	20
GeneFamily	Ankyrin repeat domain containing	ANKRD31 ANKRD13C ANK2 ANK3 ASAP3 ANKRD26 RIPK4 TRPV4 MYO16	5.73e-04	242	174	9	403
GeneFamily	PDZ domain containing	ARHGEF11 SHROOM4 PTPN13 AFDN PREX1 MPP2 CNKSR2	6.80e-04	152	174	7	1220
GeneFamily	Peptidyl arginine deiminases	PADI1 PADI2	9.04e-04	5	174	2	677
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ITPR1 UBN1 CEP192 PHACTR3 CSMD1 PCDH7 MYO16	1.87e-03	181	174	7	694
GeneFamily	Fibulins	FBLN2 HMCN2	2.48e-03	8	174	2	556
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP3 SP6	3.17e-03	9	174	2	755
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NSMAF	3.17e-03	9	174	2	1230
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	SIN3B SIN3A	3.17e-03	9	174	2	1306
Coexpression	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN	TRAF2 ADAR BRWD3 RGL1 NFIX LRRC41 CHD9 ZNF407 OAS3 ADGRG6 HTT	4.42e-06	200	254	11	M3508
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	WWC2 OSBPL11 MTCH1 ANK3 CAST CHD8 CMIP SMO ZNF639	4.57e-06	128	254	9	M4925
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	WWC2 OSBPL11 MTCH1 ANK3 CAST CHD8 CMIP SMO ZNF639	6.66e-06	134	254	9	MM748
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	SP3 ABL1 FAT1 CNOT2 CHD9 REV3L SHOC2 IGF2BP3 MLH3	1.26e-05	145	254	9	M1810
Coexpression	MATSUDA_NATURAL_KILLER_DIFFERENTIATION	PDCD1 MCM3 LYST PPARGC1A WWC2 ZBTB21 TESC MTCH1 ARMC6 DAGLB SOX6 FLNA TACC2 RHOT2 SMO LGI1	2.39e-05	486	254	16	M18517
Coexpression	ZHONG_PFC_C3_MICROGLIA	LRRC49 PTPN13 KCNB1 SNAP91 NFIX PLXNA1 LRP12 ANK2 ANK3 ATCAY TACC2 TARS3 PHACTR3 KNDC1 CSMD1 MYO16	2.51e-05	488	254	16	M39104
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MYCBP2 LRRC49 LYST PPARGC1A SNAP91 NFIX TMEM59L UNC79 PLXNA1 LRP12 ANK2 ANK3 DNAJC16 ATCAY RTN4 RHOT2 SIN3A REV3L LGR5 CMIP CELSR3 PHACTR3 CSMD1 CCDC17 PCDH7 SEZ6L	3.04e-05	1106	254	26	M39071
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	ABCA1 DAB2 UNC13D ADGRV1 LYST RGL1 WWC2 LPCAT2 TACC1 FAT4 ANK3 CAST RIPK4 ADGRG6 ELF3 GAB1	3.69e-05	504	254	16	M2157
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	SP3 GAPVD1 ABL1 FAT1 HEG1 ZC3H4 CNOT2 CHD9 REV3L SHOC2 IGF2BP3 MLH3	4.01e-05	300	254	12	M8702
Coexpression	GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN	MYCBP2 ITPR1 RGL1 HEG1 DYNC1H1 NSMAF SERTAD3 RNPEPL1 OAS3	5.33e-05	174	254	9	M6850
Coexpression	MATSUDA_NATURAL_KILLER_DIFFERENTIATION	PDCD1 MCM3 LYST PPARGC1A WWC2 ZBTB21 TESC MTCH1 ARMC6 DAGLB SOX6 FLNA TACC2 RHOT2 SMO LGI1	5.35e-05	520	254	16	MM1008
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 SPTA1 ADGRV1 PPARGC1A FAT1 DNAH5 UNC79 MGAM FAT4 CNKSR2 PHACTR3 CSMD1 MYO16 UNC80 DNAH11	2.01e-13	184	253	15	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 SPTA1 ADGRV1 PPARGC1A FAT1 DNAH5 UNC79 MGAM FAT4 CNKSR2 PHACTR3 CSMD1 MYO16 UNC80 DNAH11	2.01e-13	184	253	15	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 SPTA1 ADGRV1 PPARGC1A FAT1 DNAH5 UNC79 MGAM FAT4 CNKSR2 PHACTR3 CSMD1 MYO16 UNC80 DNAH11	2.01e-13	184	253	15	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LRRC49 GRIN3B DNAH5 DYNC2H1 C1orf87 DNAI2 KNDC1 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	7.60e-10	185	253	12	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	PPARGC1A FAT1 PTPN13 PROM2 PTPRZ1 COL7A1 ANK3 ANXA8 TACC2 RIPK4 ELF3 PCDH7	1.03e-09	190	253	12	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	LGR4 PPARGC1A FAT1 PTPN13 PROM2 PTPRZ1 COL7A1 ANK3 ANXA8 RIPK4 ELF3 PCDH7	1.16e-09	192	253	12	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRV1 MRTFB PTPRZ1 NFIX DNAH5 ANK3 DYNC2H1 CFAP69 CCDC17 PCDH7 CFAP46 DNAH11	1.23e-09	193	253	12	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABCA1 ABL2 MYCBP2 SHROOM4 RGL1 MRTFB LRP12 FAT4 REV3L NR3C1 PCDHGA12	9.19e-09	184	253	11	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	LGR4 PTPN13 PROM2 PTPRZ1 DNAH5 COL7A1 ANK3 ANXA8 RIPK4 TRPV4 ELF3	1.09e-08	187	253	11	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LGR4 FAT1 PTPN13 SCNN1A AFDN SOX6 ANK2 ANK3 TACC2 ELF3 PCDH7	1.77e-08	196	253	11	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KCNB1 GRIN3B DNAH5 DYNC2H1 C1orf87 ANKRD26 LGSN ZDHHC11 CFAP69 CFAP46 DNAH11	1.86e-08	197	253	11	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	MYCBP2 KCNB2 MRTFB KCNB1 SNAP91 TMEM59L UNC79 ANK3 CNKSR2 CSMD1 UNC80	2.18e-08	200	253	11	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	droplet-Tongue-nan-24m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGR4 PROM2 SCNN1A AFDN TESC PADI1 ANK3 RAB11FIP1 SP6 MAF	1.19e-07	186	253	10	18c06041c6c8a0ebac17b3c8aaebd67e652d315a
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LRRC49 DNAH5 DYNC2H1 C1orf87 DNAI2 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	1.76e-07	194	253	10	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYCBP2 KCNB1 MGA DYNC1H1 DYNC2H1 NSD1 REV3L UNC80 SEZ6L	1.85e-07	195	253	10	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	SCNN1A DNAH5 ANK3 DYNC2H1 TACC2 DNAI2 ELF3 CFAP69 CFAP46 DNAH11	1.94e-07	196	253	10	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	SCNN1A DNAH5 C1orf87 TACC2 DNAI2 ELF3 CFAP69 CCDC17 CFAP46 DNAH11	2.03e-07	197	253	10	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ITPR1 PPARGC1A MRTFB KCNB1 SNAP91 TMEM59L UNC79 CNKSR2 CSMD1 UNC80	2.13e-07	198	253	10	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRV1 WWC2 FAT1 PTPN13 SCNN1A DNAH5 ANK3 TACC2 ELF3	3.33e-07	159	253	9	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C19orf44 DNAH5 SOX6 COL11A2 PCDHGA10 PCDHGA9 ADCK1 SEZ6L DNAH11	4.55e-07	165	253	9	1703d3eb644b3c743ad3c5532b1d29ea010c79c8
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ABCA1 ADGRV1 WWC2 HEG1 TACC1 ANK3 TACC2 RAB11FIP1 MYO16	5.85e-07	170	253	9	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GRIN3B DNAH5 DYNC2H1 DNAI2 KNDC1 CFAP69 CCDC17 CFAP46 DNAH11	9.01e-07	179	253	9	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AFDN GRIN3B DNAH5 DYNC2H1 DNAI2 KNDC1 CCDC17 CFAP46 DNAH11	9.44e-07	180	253	9	92fb01b91261b3103454924cde56add337b41844
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 PTPRZ1 ANXA8 CNKSR2 RIPK4 CDCP1 TRPV4 ELF3 CDH15	1.08e-06	183	253	9	ecac1cfaff7553a60305b34d6cede6973ffb5430
ToppCell	facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 PTPRZ1 ANXA8 CNKSR2 RIPK4 CDCP1 TRPV4 ELF3 CDH15	1.08e-06	183	253	9	f6ebfd7f61e912f92bd07313cc213a171747ac03
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GRIN3B DNAH5 DYNC2H1 C1orf87 DNAI2 CFAP69 CCDC17 CFAP46 DNAH11	1.24e-06	186	253	9	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTPRZ1 AFDN SOX6 PCDHGA9 BCAN REV3L PCDHGA12 AGRN UNC80	1.24e-06	186	253	9	10565fce7e1b4ec88bc8e1ed6410a83800be5014
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	ABCA1 UNC13D WWC2 HEG1 PLXNA1 FLNA ANXA8 AGRN MYO16	1.30e-06	187	253	9	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 PPARGC1A PROM2 TACC1 ANK2 SLC43A1 MALRD1 AACS PADI2	1.30e-06	187	253	9	85e58a312fc325e4063a2d250666b99b8f99beb6
ToppCell	21-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	GRIN3B DNAH5 DNAI2 KNDC1 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	1.30e-06	187	253	9	1a2178a195d078d1963947b327c6d0d4f2f48341
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	GRIN3B DNAH5 DYNC2H1 C1orf87 DNAI2 AGBL2 CCDC17 CFAP46 DNAH11	1.35e-06	188	253	9	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ADGRV1 PTPN13 SCNN1A DNAH5 ANK3 TACC2 RAB11FIP1 ELF3 DNAH11	1.35e-06	188	253	9	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	ADGRV1 WWC2 PTPN13 SCNN1A DNAH5 ANK3 TACC2 RAB11FIP1 ELF3	1.35e-06	188	253	9	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	SLC39A11 TBC1D2 SCNN1A DNAH5 HKDC1 TACC2 CMIP ARRB1 KNDC1	1.41e-06	189	253	9	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KIRREL3 EHBP1L1 HEG1 FBLN2 KCNB1 LPCAT2 ADGRG6 CMIP TRPV4	1.48e-06	190	253	9	d072bb285bd34d518b958e7c9ad44739c60b359c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 AFDN SOX6 MGAM ANK3 TACC2 TRPV4 ELF3 PCDH7	1.54e-06	191	253	9	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LGR4 PPARGC1A FAT1 PTPN13 SCNN1A AFDN SOX6 ANK3 TACC2	1.68e-06	193	253	9	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 AFDN SOX6 MGAM ANK3 TACC2 TRPV4 ELF3 PCDH7	1.76e-06	194	253	9	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LGR4 PPARGC1A FAT1 PTPN13 SCNN1A SOX6 ANK3 HKDC1 ELF3	1.76e-06	194	253	9	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 AFDN SOX6 MGAM ANK3 TACC2 TRPV4 ELF3 PCDH7	1.76e-06	194	253	9	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH5 DYNC2H1 C1orf87 DNAI2 ELF3 CFAP69 CCDC17 CFAP46 DNAH11	1.76e-06	194	253	9	958e648138676d46698090b4046cb484083ae449
ToppCell	BL-critical-LOC-Epithelial-unknown_epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LRRC49 NFIX GRIN3B LRRC41 CFAP298 MZF1 LRRCC1 CFAP69 CCDC17	1.76e-06	194	253	9	6140ff8e776429c9593607da418b2d9c4f399d41
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH5 ANK3 DYNC2H1 TACC2 DNAI2 ELF3 CFAP69 CFAP46 DNAH11	1.83e-06	195	253	9	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 TBC1D2 UNC13D WWC2 SCNN1A RAB11FIP1 ARRB1 MYO16 GAB1	1.83e-06	195	253	9	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH5 ANK3 DYNC2H1 TACC2 DNAI2 ELF3 CFAP69 CFAP46 DNAH11	1.83e-06	195	253	9	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH5 DYNC2H1 C1orf87 DNAI2 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	1.83e-06	195	253	9	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 MYCBP2 KCNB1 MGA DYNC1H1 DYNC2H1 REV3L UNC80 SEZ6L	1.83e-06	195	253	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH5 ANK3 DYNC2H1 TACC2 DNAI2 ELF3 CFAP69 CFAP46 DNAH11	1.83e-06	195	253	9	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADGRV1 WWC2 PTPN13 SCNN1A AFDN DNAH5 ANK3 TACC2 ELF3	1.83e-06	195	253	9	9406866f99555198a9be311fbd65751b70f35446
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH5 DYNC2H1 C1orf87 DNAI2 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	1.83e-06	195	253	9	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNB2 MRTFB KCNB1 SNAP91 TMEM59L UNC79 CNKSR2 CSMD1 UNC80	1.91e-06	196	253	9	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Epithelial_cells-AT1_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	ABCA1 UNC13D HEG1 PLXNA1 FLNA ANXA8 CNKSR2 RAB11FIP1 AGRN	1.91e-06	196	253	9	6c99d29162848161c1f166a032320f87a5d5a631
ToppCell	3'-Adult-SmallIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEP1B PREX1 SOX6 MGAM HKDC1 MYRFL MALRD1 FCRL5 MAF	1.99e-06	197	253	9	1614bc5f41fd2c8385e58ed6b87ef1536421f29a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	GLYCTK COL6A5 ANK2 CILP DYNC2H1 CNKSR2 IKBKE PHACTR3 MYO16	2.08e-06	198	253	9	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	Epithelial_cells-AT1-AT2_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	ABCA1 UNC13D WWC2 HEG1 PLXNA1 ANXA8 RAB11FIP1 PHACTR3 AGRN	2.08e-06	198	253	9	fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-I_(AT1)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ABCA1 UNC13D WWC2 HEG1 PLXNA1 ANXA8 CNKSR2 RAB11FIP1 AGRN	2.16e-06	199	253	9	5a002d49a8b84c158f7b4d7a3e78e6a937757bb7
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LGR4 PPARGC1A PROM2 PTPRZ1 PADI1 RIPK4 TRPV4 ELF3 PCDH7	2.16e-06	199	253	9	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	WWC2 SCNN1A PLXNA1 ANXA8 TACC2 RAB11FIP1 PHACTR3 ELF3 AGRN	2.26e-06	200	253	9	3d51aebf626dd4656ab4aac8a20d761b8062c42d
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PPARGC1A PTPRZ1 SOX6 BCAN CSMD1 PCDH7 MYO16 UNC80 SEZ6L	2.26e-06	200	253	9	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GAPVD1 SCNN1A AFDN ANK3 CAST TACC2 RAB11FIP1 CFAP298 ELF3	2.26e-06	200	253	9	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PPARGC1A PTPRZ1 SOX6 BCAN CSMD1 PCDH7 MYO16 UNC80 SEZ6L	2.26e-06	200	253	9	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PPARGC1A PTPRZ1 SOX6 BCAN CSMD1 PCDH7 MYO16 UNC80 SEZ6L	2.26e-06	200	253	9	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GRIN3B DNAH5 C1orf87 DNAI2 KNDC1 AGBL2 CCDC17 CFAP46 DNAH11	2.26e-06	200	253	9	31d75c26055177d656df1fbb10b764cebd61e122
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CEP68 HEG1 FBLN2 AFDN TACC1 SOX6 BCAN CMIP CSMD1	2.26e-06	200	253	9	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PPARGC1A PTPRZ1 SOX6 BCAN CSMD1 PCDH7 MYO16 UNC80 SEZ6L	2.26e-06	200	253	9	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GRIN3B DNAH5 C1orf87 DNAI2 KNDC1 AGBL2 CCDC17 CFAP46 DNAH11	2.26e-06	200	253	9	e1dce91c6c531bb212002a14705e496d77ad3490
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PPARGC1A PTPRZ1 SOX6 BCAN CSMD1 PCDH7 MYO16 UNC80 SEZ6L	2.26e-06	200	253	9	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PPARGC1A PTPRZ1 SOX6 BCAN CSMD1 PCDH7 MYO16 UNC80 SEZ6L	2.26e-06	200	253	9	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TBC1D2 PTPN13 PTPRZ1 SCNN1A COL7A1 ANK3 ANXA8 RIPK4 ELF3	2.26e-06	200	253	9	2a9d715aba8bdef2341b0d44ff60825c074a4b03
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN13 ANK3 DYNC2H1 CDCP1 RP1L1 DHX34 PCDH7 LGI1	3.32e-06	157	253	8	2c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCell	Control-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PDCD1 WWC2 FBLN2 SERTAD3 ANK2 ANK3 PCDHGA12 FCRL5	4.19e-06	162	253	8	aa80452b972bb8ad3670ffaba4ce26fadb33b185
ToppCell	Basal_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	PODNL1 LGR4 PTPRZ1 TMEM59L COL7A1 ANXA8 LGR5 SMO	5.02e-06	166	253	8	23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH5 DYNC2H1 DNAI2 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	5.73e-06	169	253	8	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 PDCD1 ITGAD MPP2 ANK3 ATCAY OOSP2 MAF	6.25e-06	171	253	8	6f49537f8d3cf18e65aa999fec32ed347ce2da3e
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 PDCD1 ITGAD MPP2 ANK3 ATCAY OOSP2 MAF	6.25e-06	171	253	8	ab97ae2b127a585f170f028f1c475cdd1b0cdea5
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	KCNB2 SNAP91 UNC79 ANK2 ATCAY CDCP1 CELSR3 UNC80	6.25e-06	171	253	8	b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ADGRV1 PROM2 SCNN1A ESYT3 CELSR3 ELF3 ZDHHC11 AGRN	7.10e-06	174	253	8	edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ADGRV1 PROM2 SCNN1A ESYT3 CELSR3 ELF3 ZDHHC11 AGRN	7.10e-06	174	253	8	65539f69100db0b7d90b1b39ee15ab8281f86461
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LYST PPARGC1A HEG1 CAST NSD1 CHD9 NR3C1 PCDH7	7.72e-06	176	253	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A5 PTPN13 SCNN1A ELF3 PCDH7 MYO16 GAB1 MAF	8.04e-06	177	253	8	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRZ1 PADI1 ANXA8 CNKSR2 RIPK4 TRPV4 ELF3 CDH15	8.38e-06	178	253	8	fb8f8d95f6b08378fb42c4076ee040276faa296f
ToppCell	facs-Lung-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTPRZ1 PADI1 ANXA8 CNKSR2 RIPK4 TRPV4 ELF3 CDH15	8.38e-06	178	253	8	b89c4d015b44bf538aa39969ef8778877c8023f1
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 PDCD1 SLC39A11 UNC13D PTPN13 LPCAT2 TESC PADI2	9.09e-06	180	253	8	67b062f2ef7e20f392e00c646f4985c415d40de9
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN13 PTPRZ1 SOX6 ANK3 CNKSR2 DNAI2 CSMD1 LGI1	9.09e-06	180	253	8	dad458398683ff80a6e207bdc08e257d1bb757d6
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BRWD3 FBLN2 C14orf93 EVC2 ADGRG6 ESYT3 PPM1F SMO	9.09e-06	180	253	8	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BRWD3 FBLN2 C14orf93 EVC2 ADGRG6 ESYT3 PPM1F SMO	9.09e-06	180	253	8	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 PDCD1 SLC39A11 UNC13D PTPN13 LPCAT2 TESC PADI2	9.09e-06	180	253	8	b28363626f4d2a552abde3434cc1df2e2121aba5
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN13 PTPRZ1 SOX6 ANK3 CNKSR2 DNAI2 CSMD1 LGI1	9.09e-06	180	253	8	d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BRWD3 FBLN2 C14orf93 EVC2 ADGRG6 ESYT3 PPM1F SMO	9.09e-06	180	253	8	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRIN3B DNAH5 C1orf87 LGSN DNAI2 CCDC17 CFAP46 DNAH11	9.47e-06	181	253	8	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	GAPVD1 DENND4A SPTA1 ATG2A USP7 TESC SOX6 ATG2B	9.85e-06	182	253	8	0c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGR4 PTPN13 ANK3 CIAO3 CSMD1 AGRN UNC80 LGI1	9.85e-06	182	253	8	6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	GRIN3B C1orf87 DNAI2 TRPV4 AGBL2 CCDC17 CFAP46 DNAH11	9.85e-06	182	253	8	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	FAT1 PTPN13 PTPRZ1 COL7A1 ANK3 ANXA8 RIPK4 ELF3	9.85e-06	182	253	8	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBC1D2 UNC13D ADGRV1 WWC2 SCNN1A TACC2 RAB11FIP1 ESYT3	1.03e-05	183	253	8	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D231\|Adult / Lineage, Cell type, age group and donor	NUTM2D ADGRV1 SHROOM4 CFAP298 CELSR3 ELF3 LGI1	1.06e-05	132	253	7	8d30b71776f5f6da55dc78e0c5cb27be460004e3
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13D WWC2 SCNN1A TACC2 RAB11FIP1 ARRB1 PHACTR3 MYO16	1.07e-05	184	253	8	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	UNC13D PPARGC1A WWC2 SCNN1A AFDN TACC2 RAB11FIP1 MYO16	1.07e-05	184	253	8	561592edc3083fad41b91811151b442207c65dd9
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH5 DYNC2H1 DNAI2 AGBL2 CFAP69 CCDC17 CFAP46 DNAH11	1.11e-05	185	253	8	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_1\|390C / Donor, Lineage, Cell class and subclass (all cells)	EPHX2 FBXL18 SEC24B OSBPL11 FAM131A CDC14A IKBKE MZF1	1.15e-05	186	253	8	064b6047215597465bb51a8a1547ef5a226552f9
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	ARHGEF11 LYST TACC1 PADI1 ARMC6 BAHCC1 MPP2 ASAP3 OAS2 NR3C1 CELSR3 IKBKE DHX34	2.39e-07	191	253	13	5234_DN
Drug	Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	LYST PLD2 PADI1 LRRC41 BAHCC1 LRP12 ASAP3 OAS3 MLH3 IKBKE PPM1F AGRN HTT	2.86e-07	194	253	13	5630_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	LEMD3 DAB2 MRTFB ZC3H4 SEC24B CDC42EP2 OSBPL11 CNOT2 CHD9 TACC2 NR3C1 IGF2BP3	8.72e-07	180	253	12	4541_DN
Drug	Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ABCA1 KMT2B LGR4 CEP68 LRRC41 LRP12 DYNC2H1 OAS3 NR3C1 MLH3 PADI2 ZNF639	2.03e-06	195	253	12	5021_DN
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ABCA1 ABL2 CHAT AFDN LRP12 IPO8 CILP DNAJC16 CASP1 OAS2 MZF1 AGBL2	2.38e-06	198	253	12	5492_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	EPS15 LGR4 MRTFB PIK3CB SEC24B MGA CHD9 TACC2 CEP192 REV3L IGF2BP3	3.54e-06	171	253	11	7535_DN
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	KMT2B CUL7 PNPLA6 FBXL18 CDC42EP2 COL7A1 C14orf93 LRP12 OAS3 BCAN ZNF639	1.12e-05	193	253	11	2894_DN
Drug	Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A	TBC1D2 EHBP1L1 HEG1 FBXL18 ARMC6 LRP12 DNAJC16 CASP1 OAS2 NR3C1 MZF1	1.24e-05	195	253	11	7323_UP
Drug	DO 897/99; Up 200; 8.2uM; HL60; HG-U133A	KMT2B DAB2 ARHGEF11 HEG1 FBXL18 PLD2 C14orf93 CAST RHOT2 CDCP1 SEZ6L	1.30e-05	196	253	11	1728_UP
Drug	Enoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A	LYST ITPR1 WWC2 EHBP1L1 PADI1 ARMC6 BAHCC1 AMBRA1 OAS2 NR3C1 DHX34	1.36e-05	197	253	11	5616_DN
Drug	Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A	PODNL1 ARHGEF11 UBA7 COL7A1 C14orf93 LRP12 DNAJC16 ASAP3 BCAN NR3C1 GAB1	1.36e-05	197	253	11	2773_UP
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A	EPHX2 ABCA1 ITPR1 EHBP1L1 PLD2 MPP2 CASP1 ANKRD26 BCAN CDC14A ZNF639	1.36e-05	197	253	11	2892_DN
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A	PODNL1 TRAF2 ABL2 USP7 PADI1 MPP2 LRP12 RNPEPL1 CASP1 OAS2 DHX34	1.36e-05	197	253	11	6055_DN
Drug	Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	TBC1D2 ARHGEF11 PNPLA6 SCNN1A PADI1 LRRC41 IPO8 PCDHGA10 ANKRD26 MZF1 PPM1F	1.43e-05	198	253	11	7017_UP
Drug	Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; HL60; HT_HG-U133A	ARHGEF11 HEG1 MRTFB AFDN LRRC41 BAHCC1 ANK3 ANKRD26 OAS2 CDCP1 HTT	1.50e-05	199	253	11	3138_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A	PODNL1 WWC2 HEG1 MGAM CAST BSDC1 AMBRA1 RHOT2 MZF1 PPM1F HTT	1.50e-05	199	253	11	1970_UP
Drug	Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ADAM20 ARHGEF11 EHBP1L1 HEG1 TMEM59L PADI1 C14orf93 FAT4 DNAH17 DHX34 SEZ6L	1.50e-05	199	253	11	5094_UP
Drug	Sulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A	TRAF2 ABL2 CEP68 CDC42EP2 ALDH5A1 MPP2 RNPEPL1 CASP1 OAS2 NR3C1 MAF	1.50e-05	199	253	11	3449_UP
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	EPHX2 PODNL1 CUL7 AFDN PADI1 ANK2 ASAP3 CASP1 ANKRD26 OAS2 OAS3	1.57e-05	200	253	11	6005_UP
Drug	allylbenzene	EPHX2 SP3 UBA7	2.65e-05	6	253	3	CID000009309
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	LEMD3 MRTFB ZC3H4 SEC24B OSBPL11 MGA CNOT2 CHD9 TACC2 REV3L	3.86e-05	182	253	10	3887_DN
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	ATG2A CEP68 RGL1 FBXL18 STOML1 COL7A1 ASAP3 RAB11FIP1 ELF3 CFAP69	3.86e-05	182	253	10	7503_UP
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	CHAT ITPR1 UBA7 TMEM59L SCNN1A DYNC2H1 CAST IKBKE DNAI2 ELF3	5.31e-05	189	253	10	3165_UP
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	LYST FBXL18 AFDN DYNC2H1 CASP1 HKDC1 RIPK4 CDC14A ARRB1 MZF1	5.80e-05	191	253	10	7417_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	LGR4 PLXNA1 LRRC41 BAHCC1 COL7A1 ANK2 DYNC2H1 ZNF407 PADI2 DHX34	6.06e-05	192	253	10	2699_DN
Drug	Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A	PODNL1 MEP1B SCNN1A PCDHGA10 OAS2 ZNF407 ARRB1 IKBKE PPM1F MAF	6.33e-05	193	253	10	7229_UP
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	EPHX2 PODNL1 TBC1D2 ITPR1 EHBP1L1 STOML1 USP7 LRP12 FAM131A CDC14A	6.33e-05	193	253	10	3378_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA	ARHGEF11 ITPR1 UBA7 PIK3CB C14orf93 IPO8 NR3C1 IKBKE DNAI2 ZNF639	6.33e-05	193	253	10	997_UP
Drug	Althiazide [5588-16-9]; Up 200; 10.4uM; HL60; HT_HG-U133A	LRRC49 CUL7 KCNB1 STOML1 PADI1 OAS3 CDC14A DHX34 SEZ6L MAF	6.61e-05	194	253	10	2527_UP
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	TRAF2 ITPR1 EHBP1L1 PNPLA6 ASAP3 ANKRD26 CDC14A IKBKE MZF1 DHX34	6.61e-05	194	253	10	5641_DN
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	CUL7 ITPR1 ALDH5A1 IPO8 ANK3 DYNC2H1 FAM131A NR3C1 CELSR3 IKBKE	6.91e-05	195	253	10	834_UP
Drug	15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A	CEP68 HEG1 SCNN1A PLD2 ASAP3 ANKRD26 OAS2 FAM131A ARRB1 ELF3	6.91e-05	195	253	10	5228_DN
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A	KMT2B WDR55 ZNF407 DNAI2 ELF3 SMO CFAP69 DHX34 AGRN ZNF639	7.21e-05	196	253	10	4307_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CDC42EP2 TESC PLXNA1 PADI1 ANK3 ANKRD26 AMBRA1 FAM131A PPM1F DNAH17	7.21e-05	196	253	10	1684_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A	ABCA1 KMT2B LEMD3 CUL7 WWC2 OSBPL11 ALDH5A1 OSTM1 ANKRD26 BSDC1	7.52e-05	197	253	10	1826_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	PODNL1 WDR55 CUL7 CEP68 COL7A1 CAST ASAP3 CDC14A SMO CFAP69	7.52e-05	197	253	10	3728_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	EHBP1L1 MPP2 ANK3 ANKRD26 OAS2 NR3C1 CDC14A MZF1 DHX34 PCDH7	7.52e-05	197	253	10	3270_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	EPHX2 PODNL1 ABCA1 SCNN1A AFDN LRP12 ZNF407 NR3C1 DNAH17 TRPV4	7.52e-05	197	253	10	5563_UP
Drug	NS-398; Down 200; 10uM; MCF7; HT_HG-U133A	TRAF2 ATG2A ARHGEF11 EHBP1L1 FBXL18 STOML1 PADI1 FAM131A NR3C1 ARRB1	7.52e-05	197	253	10	6897_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	ATG2A EHBP1L1 UBA7 CDC42EP2 TESC C14orf93 IPO8 ANKRD26 MZF1 DHX34	7.52e-05	197	253	10	1669_UP
Drug	Azaperone [1649-18-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	SPTA1 TBC1D2 CHAT CUL7 LYST HEG1 SCNN1A CASP1 OAS2 FAM131A	7.52e-05	197	253	10	3573_UP
Drug	5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA	ARHGEF11 TACC1 ARMC6 BAHCC1 MPP2 ANK3 DYNC2H1 MZF1 ELF3 GAB1	7.84e-05	198	253	10	889_DN
Drug	Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; HL60; HT_HG-U133A	CUL7 HEG1 STOML1 SEC24B ARMC6 COL7A1 LRP12 OAS2 CDCP1 DHX34	7.84e-05	198	253	10	2905_UP
Drug	Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A	ABL2 TBC1D2 HEG1 TACC1 TESC ARMC6 COL7A1 IPO8 BCAN CELSR3	7.84e-05	198	253	10	6478_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A	TBC1D2 EHBP1L1 PNPLA6 CDC42EP2 MPP2 ASAP3 CASP1 NR3C1 IKBKE MAF	8.18e-05	199	253	10	6783_UP
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	KMT2B STOML1 AFDN MPP2 COL7A1 ANK2 RNPEPL1 OAS3 CIAO3 DNAH17	8.18e-05	199	253	10	3097_UP
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A	EPHX2 ITPR1 USP7 PADI1 BAHCC1 ASAP3 CNKSR2 NR3C1 DNAI2 DHX34	8.18e-05	199	253	10	1482_UP
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	EPHX2 EHBP1L1 UBA7 PLXNA1 PADI1 ASAP3 OAS2 FAM131A CDC14A GAB1	8.18e-05	199	253	10	6033_DN
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	ABL2 TACC1 LRRC41 IPO8 DYNC2H1 CASP1 OAS3 NR3C1 DBR1 ZNF639	8.18e-05	199	253	10	2855_DN
Drug	Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	TRAF2 ABCA1 EHBP1L1 HEG1 PIK3CB NFIX ARMC6 CASP1 MZF1 DHX34	8.18e-05	199	253	10	5781_DN
Drug	Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A	EHBP1L1 HEG1 STOML1 PADI1 COL7A1 C14orf93 OAS2 IKBKE MZF1 GAB1	8.18e-05	199	253	10	5637_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	HEG1 PNPLA6 STOML1 ALDH5A1 CASP1 OAS2 CDC14A DNAH17 DNAI2 MAF	8.18e-05	199	253	10	5421_DN
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	WDR55 CHAT RGL1 EHBP1L1 UBA7 KCNB1 CDC42EP2 LRP12 CASP1 CFAP69	8.18e-05	199	253	10	6773_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A	HEG1 UBA7 KCNB1 FAT4 ANK2 CILP CNKSR2 AGBL2 CDH15 ZNF639	8.53e-05	200	253	10	4447_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	LYST ITPR1 RGL1 TESC ASAP3 RIPK4 RAB11FIP1 CFAP69 PADI2	1.70e-04	177	253	9	6493_UP
Drug	AC1NSPXR	PLB1 ANK2 ANK3	2.09e-04	11	253	3	CID005313815
Drug	farglitazar	PPARGC1A SCNN1A NR3C1	2.09e-04	11	253	3	ctd:C422415
Drug	2-chloropropionate	ZBTB21 GRIN3B DNAH5 DYNC1H1	2.14e-04	27	253	4	CID000011734
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ABL1 LEMD3 MRTFB ZC3H4 SEC24B MGA CNOT2 CHD9 MLH3	2.27e-04	184	253	9	2321_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	TBC1D2 LYST ITPR1 RGL1 KCNB1 CILP ASAP3 CFAP69 MAF	2.27e-04	184	253	9	3643_UP
Drug	diethyl 4-methoxyphenyl phosphate	CHAT SCNN1A ANK3 OSTM1 NR3C1	2.29e-04	50	253	5	CID011207678
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	KMT2B CEP68 STOML1 CDC42EP2 TACC1 LRRC41 IKBKE PPM1F DBR1	2.45e-04	186	253	9	916_DN
Drug	Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A	ABCA1 KCNB1 TMEM59L CILP ASAP3 ZNF407 NR3C1 TRPV4 CFAP69	2.55e-04	187	253	9	3386_UP
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	SCNN1A CDC42EP2 PLD2 CASP1 OAS2 ZNF407 OAS3 MZF1 GAB1	2.66e-04	188	253	9	5490_UP
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A	LYST ITPR1 HEG1 SCNN1A AFDN ARMC6 C14orf93 ELF3 CDH15	2.76e-04	189	253	9	6895_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	LRRC49 CEP68 FBXL18 STOML1 CDC42EP2 BAHCC1 RNPEPL1 PPM1F AGRN	2.76e-04	189	253	9	5578_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A	TBC1D2 CEP68 RGL1 HEG1 PTPN13 MRTFB RHOT2 CFAP69 PADI2	2.99e-04	191	253	9	2137_UP
Drug	Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	WDR55 CEP68 TESC PLD2 LRRC41 MPP2 ANKRD26 ARRB1 PCDH7	2.99e-04	191	253	9	5442_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	ITPR1 RGL1 HEG1 TMEM59L MPP2 ASAP3 ZNF407 GAB1 MAF	3.10e-04	192	253	9	3332_UP
Drug	Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A	EPHX2 KMT2B CEP68 PTPN13 STOML1 CDC42EP2 BAHCC1 DNAJC16 OAS2	3.22e-04	193	253	9	4616_DN
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A	EHBP1L1 HEG1 STOML1 ATXN3 BAHCC1 MPP2 LRP12 OAS3 FAM131A	3.22e-04	193	253	9	5628_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	LGR4 CEP68 RAB1A DYNC2H1 RHOT2 RIPK4 REV3L PADI2 HTT	3.22e-04	193	253	9	7014_DN
Drug	3-aminopropanal	ALDH5A1 CASP1 AASDH SMO	3.25e-04	30	253	4	CID000000075
Drug	NSC-351324	PTPRZ1 NSD1 OAS2 NR3C1 LGI1	3.30e-04	54	253	5	CID000336564
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	DENND4A EHBP1L1 STOML1 MPP2 C14orf93 IPO8 DYNC2H1 NR3C1 MLH3	3.35e-04	194	253	9	6927_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A	KMT2B TBC1D2 ITPR1 EHBP1L1 STOML1 LRP12 ANKRD26 CDC14A PPM1F	3.35e-04	194	253	9	3910_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	WDR55 CUL7 CEP68 PNPLA6 PLD2 PADI1 RHOT2 IKBKE DHX34	3.35e-04	194	253	9	6833_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	TRAF2 CEP68 EHBP1L1 CDC42EP2 PLXNA1 OAS3 FAM131A NR3C1 PPM1F	3.35e-04	194	253	9	1707_DN
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	KMT2B PNPLA6 TESC OAS2 CDC14A IKBKE DNAI2 DHX34 ZNF639	3.35e-04	194	253	9	5384_DN
Drug	Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A	KMT2B TBC1D2 CDC42EP2 PLD2 PADI1 ARMC6 LRP12 IPO8 BCAN	3.35e-04	194	253	9	6467_DN
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A	KMT2B CUL7 ITPR1 CEP68 PLXNA1 ARMC6 LRP12 RIPK4 IKBKE	3.35e-04	194	253	9	2840_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	DENND4A SPTA1 ARHGEF11 MPP2 LRP12 RNPEPL1 NR3C1 CDC14A ZNF639	3.35e-04	194	253	9	5303_UP
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A	NFATC4 SCNN1A AFDN PLD2 BAHCC1 ZNF407 CIAO3 PCDH7 ZNF639	3.48e-04	195	253	9	5878_UP
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PODNL1 WDR55 ARHGEF11 HEG1 CDC42EP2 ASAP3 CASP1 IKBKE DHX34	3.48e-04	195	253	9	5460_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ITPR1 TESC BAHCC1 LRP12 IPO8 RNPEPL1 OAS3 CELSR3 IKBKE	3.48e-04	195	253	9	4980_DN
Drug	Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A	ABCA1 ATXN3 TACC1 PADI1 LRP12 IPO8 NR3C1 ARRB1 CELSR3	3.48e-04	195	253	9	3942_DN
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A	TRAF2 HEG1 MRTFB AFDN ANKRD26 CDCP1 CDC14A MLH3 DHX34	3.48e-04	195	253	9	3135_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A	DAB2 EHBP1L1 FBXL18 AFDN BAHCC1 FLII BSDC1 RHOT2 GAB1	3.48e-04	195	253	9	2942_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ABL2 LYST COL7A1 RNPEPL1 OAS2 FAM131A BCAN ARRB1 DNAH17	3.48e-04	195	253	9	2278_DN
Drug	Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CDC42EP2 TACC1 PADI1 MPP2 ANK3 ARRB1 CELSR3 PPM1F DHX34	3.48e-04	195	253	9	1704_DN
Drug	Cinoxacin [28657-80-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	TRAF2 DENND4A USP7 CDC42EP2 SLC43A1 ASAP3 CASP1 ANKRD26 AMBRA1	3.48e-04	195	253	9	5783_DN
Drug	tetraketide	LYST CASP1 LGSN	3.57e-04	13	253	3	CID006475274
Drug	5-phenylhydantoin	EPHX2 MCPH1 NR3C1	3.57e-04	13	253	3	CID000001002
Drug	poly r(A-U	OAS2 OAS3 IKBKE	3.57e-04	13	253	3	CID000032741
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	EPHX2 LYST CEP68 FBXL18 ALDH5A1 RAB11FIP1 PPM1F DHX34 AGRN	3.61e-04	196	253	9	2874_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	LRRC49 WWC2 HEG1 FBXL18 COL7A1 CASP1 MLH3 CFAP69 DHX34	3.61e-04	196	253	9	5833_DN
Drug	rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	ITPR1 EHBP1L1 FBXL18 CDC42EP2 PADI1 LRRC41 OAS3 RIPK4 ZNF639	3.61e-04	196	253	9	5593_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	KMT2B FBXL18 USP7 BAHCC1 IPO8 CDC14A MZF1 PPM1F DHX34	3.61e-04	196	253	9	5569_DN
Drug	Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A	ITPR1 KCNB1 STOML1 AFDN ASAP3 LGR5 DNAH17 TRPV4 AGBL2	3.61e-04	196	253	9	4409_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; HL60; HT_HG-U133A	AFDN PADI1 LRRC41 FLII NSD1 OAS2 CNKSR2 ARRB1 CFAP69	3.61e-04	196	253	9	2571_DN
Disease	sexual dimorphism measurement	ANKRD31 GAPVD1 ABCA1 KMT2B LGR4 KCNB2 EHBP1L1 CCDC66 UBN1 NFATC4 ZC3H4 MED22 ATXN3 MIGA1 MGA MPP2 MGAM COL7A1 UVSSA RTN4 NSD1 RHOT2 NR3C1 ADGRG6 IGF2BP3 CMIP CIAO3 SP6	2.76e-07	1106	250	28	EFO_0021796
Disease	nephrotic syndrome (implicated_via_orthology)	GAPVD1 COQ8B KIRREL3 FAT1 SCNN1A	1.56e-06	24	250	5	DOID:1184 (implicated_via_orthology)
Disease	CHARGE syndrome (implicated_via_orthology)	CHD6 CHD9 CHD8	2.05e-05	7	250	3	DOID:0050834 (implicated_via_orthology)
Disease	Bronchiectasis	SCNN1A DNAH5 DNAI2 DNAH11	3.26e-05	22	250	4	C0006267
Disease	Ciliopathies	ADGRV1 SCNN1A DNAH5 EVC2 DYNC2H1 NEK8 DNAH11	4.37e-05	110	250	7	C4277690
Disease	Primary Ciliary Dyskinesia	STK36 DNAH5 CFAP298 DNAI2 DNAH11	4.81e-05	47	250	5	C4551720
Disease	Disproportionate short stature	CUL7 FLNA EVC2 COL11A2 DYNC2H1 TRPV4	5.00e-05	77	250	6	C0878659
Disease	lymphocyte count	ABL1 SPTA1 ARHGEF11 LYST ITPR1 CCDC66 FBXL18 NFIX USP7 C19orf44 PREX1 NSMAF DNMT1 DAGLB PCDHGB3 PCDHGA10 PCDHGA9 RTN4 NSD1 HKDC1 CMIP SBNO1 IKBKE PCDHGA12 DNAH17 SP6 AGBL2 HTT	5.30e-05	1464	250	28	EFO_0004587
Disease	Kartagener syndrome (implicated_via_orthology)	DNAH5 DNAI2 DNAH11	2.04e-04	14	250	3	DOID:0050144 (implicated_via_orthology)
Disease	Primary ciliary dyskinesia	DNAH5 CFAP298 DNAI2 DNAH11	2.39e-04	36	250	4	cv:C0008780
Disease	infant head circumference	PREX1 IGF2BP3 SBNO1	2.54e-04	15	250	3	EFO_0004577
Disease	congenital heart disease (implicated_via_orthology)	KMT2B ITPR1 CHD6 CHD9 CHD8	3.03e-04	69	250	5	DOID:1682 (implicated_via_orthology)
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB3 PCDHGA10 PCDHGA9 CNKSR2 PCDHGA12	3.46e-04	71	250	5	EFO_0007878, EFO_0007979
Disease	Colorectal Carcinoma	ABCA1 KCNB2 FAT1 FBLN2 COL7A1 EVC2 ANK2 RNPEPL1 RTN4 ASAP3 CNKSR2 LGR5 CDC14A MLH3 PPM1F MAF	3.55e-04	702	250	16	C0009402
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	LYST NSMAF	4.24e-04	4	250	2	DOID:2935 (implicated_via_orthology)
Disease	Kartagener syndrome (is_implicated_in)	DNAH5 DNAH11	4.24e-04	4	250	2	DOID:0050144 (is_implicated_in)
Disease	hemoglobin A1 measurement	SPTA1 UNC13D ITGAD ZC3H4 MGA SOX6 MGAM CAST CDC14A IGF2BP3 CMIP RP1L1 SP6	5.40e-04	520	250	13	EFO_0007629
Disease	estrogen measurement, response to aromatase inhibitor	MPP2 CSMD1	7.03e-04	5	250	2	EFO_0011007, GO_0061477
Disease	neutrophil count	DENND4A MYCBP2 RC3H1 ADAR FAM186A MED22 GRIN3B PREX1 SERTAD3 DNMT1 DAGLB DYNC2H1 NSD1 CHD9 PLEKHG2 CDC14A ADGRG6 IGF2BP3 CMIP SBNO1 RP1L1 FCRL5 AGBL2 HTT	7.39e-04	1382	250	24	EFO_0004833
Disease	nicotine dependence symptom count	MYCBP2 DAB2 C17orf75 ZC3H4 RXFP2 MPP2 CNKSR2 ADGRG6 CSMD1	7.76e-04	285	250	9	EFO_0009262
Disease	neuroimaging measurement	KMT2B LRRC49 ARHGEF11 PPARGC1A SNAP91 NFIX BAHCC1 MPP2 ANK3 MCPH1 CNKSR2 TACC2 BCAN REV3L SBNO1 PCDH7 MYO16 HTT DNAH11 MAF	8.42e-04	1069	250	20	EFO_0004346
Disease	visual epilepsy (biomarker_via_orthology)	PTPRZ1 PLD2 RTN4 NR3C1 SMO	1.03e-03	90	250	5	DOID:11832 (biomarker_via_orthology)
Disease	body weight	CNBD1 GAPVD1 SLC39A11 DAB2 ADGRV1 KCNB2 ITPR1 QRFPR NFATC4 MGA UNC79 PLXNA1 MPP2 MGAM CAST BSDC1 CHD8 CNKSR2 CEP192 ADGRG6 IGF2BP3 PCDH7	1.16e-03	1261	250	22	EFO_0004338
Disease	mean platelet volume	SPTA1 MCM3 UNC13D QRFPR FBXL18 UBN1 PIK3CB USP7 TESC DAGLB PCDHGB3 PCDHGA10 PCDHGA9 RNPEPL1 CHD9 SIN3A CMIP PCDHGA12 HTT	1.19e-03	1020	250	19	EFO_0004584
Disease	mental development measurement	PCDHGB3 PCDHGA10 PCDHGA9	1.20e-03	25	250	3	EFO_0008230
Disease	body surface area	KCNB2 WWC2 FBLN2 UBN1 ZC3H4 ATXN3 UNC79 DNMT1 MCPH1 NSD1 NR3C1 ADGRG6 IGF2BP3 CIAO3	1.27e-03	643	250	14	EFO_0022196
Disease	testosterone measurement	DENND4A GLYCTK UNC13D ADAR SHROOM4 CEP68 ZC3H4 FAM186A RXFP2 USP7 DAGLB SOX6 ANK2 ANK3 CAST HKDC1 SIN3A NR3C1 CMIP KNDC1 MYO16 MAF	1.33e-03	1275	250	22	EFO_0004908
Disease	Writer's Cramp	KMT2B ALDH5A1	1.46e-03	7	250	2	C4316810
Disease	Dystonia Disorders	KMT2B ALDH5A1	1.46e-03	7	250	2	C0393593
Disease	Idiopathic familial dystonia	KMT2B ALDH5A1	1.46e-03	7	250	2	C0393598
Disease	Adult-Onset Idiopathic Focal Dystonias	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752198
Disease	Adult-Onset Dystonias	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752197
Disease	Adult-Onset Idiopathic Torsion Dystonias	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752199
Disease	Autosomal Dominant Familial Dystonia	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752200
Disease	Childhood Onset Dystonias	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752202
Disease	Autosomal Recessive Familial Dystonia	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752201
Disease	Dystonia, Primary	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752203
Disease	Dystonias, Sporadic	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752206
Disease	Dystonia, Secondary	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752205
Disease	Pseudodystonia	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752208
Disease	Familial Dystonia	KMT2B ALDH5A1	1.46e-03	7	250	2	C0752207
Disease	Focal Dystonia	KMT2B ALDH5A1	1.46e-03	7	250	2	C0743332
Disease	Schizophrenia	EPHX2 ABCA1 CHAT ARHGEF11 PPARGC1A KCNB1 PIK3CB PTPRZ1 MSS51 DNMT1 ANK3 RTN4 AMBRA1 NR3C1 SBNO1 CSMD1 MYO16	1.52e-03	883	250	17	C0036341
Disease	neurodegenerative disease (implicated_via_orthology)	PNPLA6 SCNN1A DYNC1H1 FAT4 RHOT2 HTT	1.52e-03	145	250	6	DOID:1289 (implicated_via_orthology)
Disease	preterm premature rupture of the membranes, spontaneous preterm birth	LGR4 SUCLG2 CNKSR2	1.68e-03	28	250	3	EFO_0006917, MONDO_0012511
Disease	reticulocyte measurement	ABCA1 DENND4A SPTA1 ITGAD RGL1 FAT1 ZC3H4 AFDN RAB1A PREX1 DNMT1 SOX6 FLNA RNPEPL1 NEK8 DNAH17 LTN1 SP6 SLC4A11	1.71e-03	1053	250	19	EFO_0010700
Disease	age at menarche	KCNB2 KIRREL3 SNAP91 ZC3H4 UNC79 MPP2 ADCK1 CAST CMIP PPM1F SP6 CSMD1 UNC80	1.79e-03	594	250	13	EFO_0004703
Disease	age-related hearing impairment	HEG1 SNAP91 MPP2 FOXN1 COL11A2 NSD1 CSMD1 CCDC17 SLC4A11	1.88e-03	324	250	9	EFO_0005782
Disease	cardiovascular disease	PLB1 UNC13D UBN1 RXFP2 PREX1 DNMT1 BAHCC1 SOX6 MPP2 CMIP SP6	1.92e-03	457	250	11	EFO_0000319
Disease	microcephaly (is_implicated_in)	MCPH1 NSD1	1.94e-03	8	250	2	DOID:10907 (is_implicated_in)
Disease	tyrosine-protein kinase receptor TYRO3 measurement	MGA MGAM	1.94e-03	8	250	2	EFO_0020829
Disease	procollagen galactosyltransferase 1 measurement	DAGLB COL7A1	1.94e-03	8	250	2	EFO_0801922
Disease	aspartate aminotransferase measurement	ANKRD31 PLB1 ABCA1 DAB2 WDR55 ITPR1 PPARGC1A RGL1 WWC2 HMCN2 ARMC6 SOX6 CAST NSD1 HKDC1 SHOC2 CSMD1	1.94e-03	904	250	17	EFO_0004736
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	ABCA1 LRP12 NSD1 CMIP SP6	2.04e-03	105	250	5	EFO_0007788, EFO_0008007, EFO_0008343
Disease	amino acid measurement	RGL1 FBLN2 RXFP2 AIFM3 SOX6 MPP2 FAT4 MCPH1 TACC2 SHOC2 RP1L1 CSMD1 MYO16 HTT	2.07e-03	678	250	14	EFO_0005134
Disease	Malignant neoplasm of breast	ABL1 RPS7 ADAR RGL1 PIK3CB OSBPL11 PLD2 DNMT1 FLNA COL7A1 ANK2 DYNC2H1 C1orf87 FAM131A TACC2 SBNO1 PPM1F FCRL5 GAB1	2.14e-03	1074	250	19	C0006142
Disease	hair colour measurement	LGR4 UNC13D ATG2A ADGRV1 LYST TACC1 PLXNA1 SOX6 FLII REV3L SHOC2 SP6 CDH15	2.42e-03	615	250	13	EFO_0007822
Disease	primary bacterial infectious disease (implicated_via_orthology)	DUOX2 SMO	2.47e-03	9	250	2	DOID:0050338 (implicated_via_orthology)
Disease	tetradecanedioate measurement	ANKRD26 LGI1	2.47e-03	9	250	2	EFO_0021057
Disease	seasonal allergic rhinitis	EPS15 ABL2 DNAH5	2.49e-03	32	250	3	EFO_0003956
Disease	Parkinson's disease (is_marker_for)	ABL1 PPARGC1A AFDN CAST	2.54e-03	67	250	4	DOID:14330 (is_marker_for)
Disease	Alzheimer disease	ANKRD31 ABCA1 HSP90AA4P ANK3 CDCP1 CMIP SP6 CSMD1 PCDH7 MYO16 MAF	3.03e-03	485	250	11	MONDO_0004975
Disease	longevity	SLC39A11 RC3H1 PREX1 SOX6 UVSSA CNKSR2 CSMD1 CFAP69	3.05e-03	284	250	8	EFO_0004300
Disease	coronary artery disease	ANKRD31 ABCA1 RPS7 UNC13D KCNB2 EHBP1L1 STOML1 ALDH5A1 MTCH1 PREX1 DAGLB SOX6 FAT4 DYNC2H1 DUOX2 CNKSR2 CMIP MALRD1 SP6 SEZ6L	3.07e-03	1194	250	20	EFO_0001645
Disease	temporomandibular joint disorder	RXFP2 BAHCC1	3.08e-03	10	250	2	EFO_0005279
Disease	response to carboplatin, response to antineoplastic agent	CMIP CSMD1	3.08e-03	10	250	2	GO_0097327, GO_0097328
Disease	3-methyl-2-oxobutyrate measurement	FAT4 NR3C1	3.08e-03	10	250	2	EFO_0021020
Disease	emphysema	PPARGC1A FBLN2 CSMD1	3.22e-03	35	250	3	EFO_0000464
Disease	phospholipids in large HDL measurement	ABCA1 CMIP SP6 AGBL2	3.47e-03	73	250	4	EFO_0022190
Disease	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	KCNB2 DNAH11	3.74e-03	11	250	2	EFO_0009923
Disease	Macrocephaly	BRWD3 CHD8	3.74e-03	11	250	2	C0221355
Disease	response to alcohol	WWC2 AFDN LRP12 CAST	3.82e-03	75	250	4	EFO_0005526
Disease	heart disease (implicated_via_orthology)	PPARGC1A PIK3CB SOX6	4.07e-03	38	250	3	DOID:114 (implicated_via_orthology)
Disease	Lung diseases	SCNN1A DNAH5 DNAI2 DNAH11	4.39e-03	78	250	4	C0024115
Disease	metabolite measurement, body weight gain	TACC2 DNAI2	4.46e-03	12	250	2	EFO_0004566, EFO_0004725
Disease	attention deficit hyperactivity disorder, conduct disorder	RGL1 KIRREL3 MYRFL	4.71e-03	40	250	3	EFO_0003888, EFO_0004216
Disease	body height at birth	HKDC1 ADGRG6 IGF2BP3	4.71e-03	40	250	3	EFO_0006784
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH3 PDCD1 PPARGC1A MTCH1	4.81e-03	80	250	4	DOID:12930 (implicated_via_orthology)
Disease	diastolic blood pressure, systolic blood pressure	GAPVD1 LRRC49 PPARGC1A RGL1 KCNB1 CHD6 NSMAF SOX6 ANK2 ANK3 DYNC2H1 CMIP MALRD1	4.97e-03	670	250	13	EFO_0006335, EFO_0006336
Disease	choline measurement	PLB1 ABCA1 NFATC4 ASAP3 MAF	5.09e-03	130	250	5	EFO_0010116
Disease	serum gamma-glutamyl transferase measurement	SP3 PLB1 RPS7 ARHGEF11 ITPR1 WWC2 NSMAF DNMT1 BAHCC1 DNAJC16 ASAP3 CHD9 USP16 SBNO1 RP1L1 CSMD1	5.19e-03	914	250	16	EFO_0004532
Disease	middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement	MYCBP2 CNKSR2	5.24e-03	13	250	2	EFO_0006514, EFO_0010316
Disease	longitudinal BMI measurement	MPP2 EVC2 CAST CNKSR2	5.25e-03	82	250	4	EFO_0005937
Disease	obsolete_red blood cell distribution width	SP3 ABL1 KMT2B RC3H1 SPTA1 UNC13D ITGAD EHBP1L1 ZC3H4 AFDN MIGA1 GRIN3B DAGLB SOX6 RTN4 DUOX2 ZNF407 ESYT3 RP1L1 MYO16 CDH15	5.52e-03	1347	250	21	EFO_0005192
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement	LEMD3 CMIP SP6	5.78e-03	43	250	3	EFO_0007788, EFO_0008343
Disease	Autism Spectrum Disorders	EPHX2 CHD8 SIN3A UNC80	5.96e-03	85	250	4	C1510586
Disease	caudate volume change measurement	NFATC4 CNKSR2	6.08e-03	14	250	2	EFO_0021491
Disease	glycodeoxycholate measurement	COL7A1 CSMD1	6.08e-03	14	250	2	EFO_0010493
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	FAT4 LGI1	6.08e-03	14	250	2	EFO_0004670, EFO_0006794
Disease	apolipoprotein A 1 measurement	ABCA1 RPS7 UNC13D ADAR ZC3H4 MED22 MGA DAGLB MGAM COL7A1 NSD1 CMIP SBNO1 SP6 CCDC17	6.12e-03	848	250	15	EFO_0004614
Disease	hip geometry	ADGRV1 CCDC66 MPP2	6.16e-03	44	250	3	EFO_0004685
Disease	Drugs used in diabetes use measurement	MYCBP2 NFIX NSD1 CNKSR2 ADGRG6 SP6 AGBL2	6.27e-03	255	250	7	EFO_0009924
Disease	Profound Mental Retardation	ALDH5A1 DYNC1H1 NSD1 CHD8 SIN3A	6.73e-03	139	250	5	C0020796
Disease	Mental deficiency	ALDH5A1 DYNC1H1 NSD1 CHD8 SIN3A	6.73e-03	139	250	5	C0917816
Disease	Mental Retardation, Psychosocial	ALDH5A1 DYNC1H1 NSD1 CHD8 SIN3A	6.73e-03	139	250	5	C0025363
Disease	response to radiation	BRWD3 DNAH5 IGF2BP3 CSMD1	6.73e-03	88	250	4	GO_0009314
Disease	urate measurement, bone density	PLB1 RC3H1 TBC1D2 COL6A5 ITPR1 PPARGC1A KIRREL3 MPP2 RIPK4 MYO16 SLC4A11 DNAH11	6.89e-03	619	250	12	EFO_0003923, EFO_0004531
Disease	cortical thickness	CNBD1 KMT2B MYCBP2 LRRC49 LGR4 ADGRV1 UBN1 SNAP91 NFIX TACC1 TESC FLII MCPH1 TACC2 MALRD1 AGBL2 PCDH7 MYO16	6.93e-03	1113	250	18	EFO_0004840
Disease	birth weight	DAB2 MIGA1 PREX1 DNMT1 MCPH1 HKDC1 ADGRG6 IGF2BP3 SP6	7.30e-03	399	250	9	EFO_0004344
Disease	colorectal health	ADGRV1 KCNB2 KCNB1 MPP2 LRP12 CSMD1	7.53e-03	201	250	6	EFO_0008460

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPLKLEFDFTEDTGN	TACC1	316	O75410
EAPSGALSLLDLFST	TMEM59L	141	Q9UK28
VEALIQSADTLFPGD	BARGIN	466	Q6ZT62
ILLSTTDPADFAVAE	AFDN	266	P55196
DGASILPQLFDLSSD	ARSK	431	Q6UWY0
TNLLDAPGINDVSDS	ESYT3	256	A0FGR9
EDSGPLSAEQSAALA	BAHCC1	1886	Q9P281
DLFQSFDDTPLGTAS	ADCK1	151	Q86TW2
SLEASFLTPAVGFAD	CCDC17	576	Q96LX7
NSKDEALSSAFLGEP	ASAP3	391	Q8TDY4
DPNLFGLDSLTDDSF	CHD8	11	Q9HCK8
APERIESSGNSLFLA	CSMD1	1526	Q96PZ7
DPVLQDSGVDLDSFS	CEP68	326	Q76N32
TDTVLGATSDPLELF	DNMT1	801	P26358
LLGATESDPNLFVAL	ABL2	101	P42684
APTDLRVFELNSDSG	BSDC1	361	Q9NW68
DFLATGTSEQAPQLE	AACS	261	Q86V21
NISTGDLEDFPGLDS	AIFM3	136	Q96NN9
LPTSGDLDNVLEDFS	ADAM20	266	O43506
LNLDFFGPVDDSSSS	AFTPH	826	Q6ULP2
DLFFIDGSTPSDNIV	CDC14A	246	Q9UNH5
LLQDSSGSFLQPEVD	CDCP1	746	Q9H5V8
DFESGQVDPLASVIL	ADGRG6	711	Q86SQ4
ALSVLTDGQPDLLDA	ARMC6	161	Q6NXE6
PGSLVAAILATDDDS	FAT4	1856	Q6V0I7
DAPTGTDVLLVNASD	FAT4	2376	Q6V0I7
SDSDLFVIDPNTGVI	FAT4	3236	Q6V0I7
VSNDAPEDTGTLELL	ABCA1	1391	O95477
PSGTDGLNLDTDLFV	AGRN	1481	O00468
GDEFANLTVSILPDD	ADGRV1	2516	Q8WXG9
QRLSTGSFPEDLLES	ARHGEF11	586	O15085
DLSFIFNGDAAPSES	ANKRD13C	276	Q8N6S4
LTASAGNDSEPNLID	CMIP	416	Q8IY22
EFALNLTNGSAPEET	CFAP46	836	Q8IYW2
INDLLASGEIPDLFS	DNAH11	2926	Q96DT5
DNFVSTEDPLNLGTS	BRWD3	1766	Q6RI45
PAATFGADDLVLTLS	ELF3	31	P78545
VPDESLFLNSGGDSL	AASDH	576	Q4L235
AALPGLSQDSLDFES	C8orf58	81	Q8NAV2
DLLGEDSLAALSSVP	SNAP91	381	O60641
DISADGQLLAAFIPS	AMBRA1	896	Q9C0C7
EAAAELESGSIASPL	ANKRD26	1666	Q9UPS8
NALGAISLEFESTLP	DNAI2	316	Q9GZS0
GDLASSDVAVELPFT	ARRB1	336	P49407
LELSEPQFRSELSSG	ATG2A	671	Q2TAZ0
LFLFPDESGNVSQES	ATG2B	1451	Q96BY7
SPSGTTNEDAFLLAL	C1orf87	166	Q8N0U7
TDVATGFDPLSLLVA	DENND4A	1161	Q7Z401
AEDLTLTFSDVPNGS	RC3H1	1076	Q5TC82
EFADSLGIPFLETSA	RAB1A	141	P62820
EFETSNGDSLLGLPE	NSD1	581	Q96L73
FPDADFLGLVSLSVS	PADI1	256	Q9ULC6
LFRSELAENSPLDSG	QRFPR	416	Q96P65
ETDNGLPNTISFSLE	RGL1	201	Q9NZL6
DSIPQVLADLGSLES	PCDHGA12	666	O60330
VLADLGSLESPANSE	PCDHGA12	671	O60330
PFIADFQTTAEELGL	OOSP2	136	Q86WS3
LLGFSSDESDVEASP	LEMD3	136	Q9Y2U8
AFFDSTTLDTIGNLP	LTN1	1286	O94822
DLKELGDDSLPSSQF	ANK2	866	Q01484
SSFVDPGLALQDAQD	ANXA8	171	P13928
LESVDQTEAVSFPGL	ANKRD31	826	Q8N7Z5
QAPAALADVLEGDSS	BCAN	16	Q96GW7
DISSDAFTALDPLGD	DAB2	631	P98082
ELDFFSLNPNSGVLS	FAT1	611	Q14517
ADVLAFPSSGFTDLA	PNPLA6	1281	Q8IY17
ATASGPNFSLADLES	NFIX	236	Q14938
PTSLEGLSNLADVDL	FLII	216	Q13045
LIPISDGSSDFDVND	LRP12	776	Q9Y561
LGFSPEDAVEALISN	MAF	106	O75444
DDDVPILLFESNGSL	MCPH1	146	Q8NEM0
QLNDDSVGLAELPSS	MGA	2836	Q8IWI9
GNDISSIFELDPTTL	ITPR1	361	Q14643
SIDTLGFFSLDDNVP	MSS51	41	Q4VC12
LTGNEFLSFPEEVLS	LRRIQ4	356	A6NIV6
PLDELASLFNSGRSV	MYO16	1671	Q9Y6X6
LSSEDPNLFGSNSLD	GAB1	596	Q13480
VLEEGSLFLASVSPA	HMCN2	1301	Q8NDA2
LDLDTDSADGLSAPL	MED22	156	Q15528
SLDQSEGSLLSDDFL	ATCAY	71	Q86WG3
VLFDSSIGPLLFADQ	MGAM	236	O43451
FNLNSLLTGPELISD	ATXN3	131	P54252
NLLSLANEDSVPGAD	GAPVD1	1406	Q14C86
SGSLLSVLESPENAF	IKBKE	91	Q14164
LSQKAPSLEDGSDAF	SLC43A1	261	O75387
DINQADAGTLPLDSS	DUOX2	781	Q9NRD8
EALSLGTEAELPNSL	FBLN2	586	P98095
TFSPALLVVTEGDNA	PDCD1	36	Q15116
LQLDTQLTSPDAAGE	PLXNA1	261	Q9UIW2
VLNLSSPEDLIFEGA	FCRL5	381	Q96RD9
NLEDLGLEFVFPDTS	MLH3	1281	Q9UHC1
GLEFVFPDTSDSLVL	MLH3	1286	Q9UHC1
GSDAPSILDLLVSVF	OR14K1	261	Q8NGZ2
GSLQIPADLEASDLT	PCDHGA9	676	Q9Y5G4
LADLGSFESPANSET	PCDHGA10	676	Q9Y5H3
IFAIDPDSGDILVNT	PCDH7	581	O60245
TSLLDQLNDSAAEPG	CUL7	261	Q14999
LEAFLDGTLPSANEI	MRTFB	971	Q9ULH7
EQLPVLDASFSDLGA	COL11A2	1706	P13942
TLFTLDDQALGPELT	COG8	561	Q96MW5
ADTLLPDSEAFQGKS	DNAJC16	431	Q9Y2G8
EGSLTEASLPEAQVA	EHBP1L1	991	Q8N3D4
GTLENPALDTSLLEE	MYRFL	21	Q96LU7
PALDTSLLEEFLGND	MYRFL	26	Q96LU7
EALSFTLLGSAPLDQ	NEK8	546	Q86SG6
LPFTSADGVNEDLSL	EVC2	346	Q86UK5
LSDITFDGNPIAQES	LRRC49	271	Q8IUZ0
VPEGLSAFTQALDIS	LGR4	51	Q9BXB1
FDILQDLEFSSGSPG	NR3C1	191	P04150
SPLAGEDDSFLLEGN	NR3C1	226	P04150
LDFAASLLGTEPFQE	KMT2B	1991	Q9UMN6
SLPSATGAAELDLIF	MPP2	21	Q14168
FIEPSTENEFGLTSL	HEG1	396	Q9ULI3
SDSEFLLPDTDGLTA	PTPRZ1	1001	P23471
ALTGATFALESAQDP	PCDHGB3	146	Q9Y5G1
ELLLDFANSSAELTG	OSTM1	86	Q86WC4
EPLFESVTSLDSFGN	PADI2	396	Q9Y2J8
ESVSFDVLPAFNALG	OAS2	476	P29728
DDFSLSLADTNLPSE	C17orf75	71	Q9HAS0
IGNLSENAAPSDLES	IGF2BP3	6	O00425
AVGSQDLFTASLPFE	ITGAD	751	Q13349
LPSFDALTDGDVTTD	PPARGC1A	106	Q9UBK2
EEFSTILQASLGVPD	LPCAT2	451	Q7L5N7
GSAVDILATDDPNFS	MCM3	521	P25205
SSEGLPDEAFESLTQ	PODNL1	111	Q6PEZ8
PEDSGFNSLSLEKSE	FBXO43	331	Q4G163
IDLIAEAGESTLPFQ	MALRD1	596	Q5VYJ5
TTPGAAFLLESAQDS	PCDHB7	146	Q9Y5E2
PEDLTADDFSNGLTL	DYNC2H1	2246	Q8NCM8
ESQFLLQAPGSTELE	CFAP298	11	P57076
FVASGNRTDISLDDP	CHD9	1406	Q3L8U1
TGILPDEASEAFRNS	HTT	606	P42858
SPSEVVFLDDIGANL	EPHX2	176	P34913
LPELQSLDEFGQSTD	KCNB1	211	Q14721
SLNTLPELQETDEFG	KCNB2	211	Q92953
ESGAEEPFLSNASSL	CDC42EP2	166	O14613
VSGNLSLPTTEEFED	CASP1	301	P29466
SNSTSALEDPLEFLD	ADAR	281	P55265
TPELASQAAAEGLDI	GLYCTK	466	Q8IVS8
TNGLDPLSLLTDDAD	DNAH17	3396	Q9UFH2
GVNPEEADSAFSLLA	DPH7	421	Q9BTV6
FVASGNRTDISLDDP	CHD6	1006	Q8TD26
DIPNTADSLGGLSFE	GJA9	466	P57773
SDTDLVPSDIAAGLA	DAGLB	226	Q8NCG7
GSAADIPINISETDL	FLNA	1966	P21333
SLDGLAPAVSENSDL	C19orf44	366	Q9H6X5
NAAAALDSALEESGP	C14orf93	256	Q9H972
DNFNIASDPLISDSG	COL6A5	1991	A8TX70
SSLLPLAENQEESFG	CCDC66	931	A2RUB6
SAFRSLGPLEAQDSL	FAM131A	291	Q6UXB0
ISNGALAFTPLDTAD	ABL1	641	P00519
PEDNTLLFESRFESG	AGBL2	261	Q5U5Z8
QSLATEDGFTPLAVA	ANK3	166	Q12955
SGLDSSPFLSEANAE	COQ8B	126	Q96D53
IGPDDAIDALSSDFT	CAST	226	P20810
LLDALSEDFSGPQNA	CAST	511	P20810
VESSSLQGELEPASF	LYST	3051	Q99698
GIAEESFPSFLTNSL	CEP192	6	Q8TEP8
LITLGDQDIDLSPSF	DYNC1H1	3661	Q14204
SELDLSNPGTFRDLS	NSMAF	346	Q92636
PQSLLVDLGSDAIFS	KIRREL3	341	Q8IZU9
EDFISSKILPLDGSA	KNDC1	1346	Q76NI1
PTFGDASVIALELLN	ATP5F1C	161	P36542
ENNTLGSPAASELLE	DBR1	201	Q9UK59
LVLPGSQTAFDLDDV	COL7A1	551	Q02388
SSLTGPVADTNLDFF	EPS15	606	P42566
ETALLSSDFGLEGPQ	HSP90AA4P	356	Q58FG1
GDLLESGPLTFSEQL	FAM186A	1871	A6NE01
IDADSGAITLQAPLD	CELSR3	906	Q9NYQ7
FENLPGLSAEDFVTL	CFAP69	731	A5D8W1
LRDQGALDSSEALTP	DHX34	561	Q14147
PDAGFAVQLSIEESL	SEC24B	956	O95487
TLPSLEEDTLGNFIF	SCNN1A	266	P37088
EDPQTTLALNFGSTL	SLC39A11	106	Q8N1S5
AALSESGISPNDLFD	SBNO1	11	A3KN83
TSPLDIADFINDGLE	CDH15	706	P55291
LVISGLATPENFDVD	MEP1B	16	Q16820
SDPALLEILGQASDS	DNAH5	1721	Q8TE73
ERLGSAEQSSPDLSF	PRIMPOL	251	Q96LW4
FPDLTGTANLESLTL	LGR5	321	O75473
LPEFGISSADNAFTL	LGSN	271	Q5TDP6
AEETPGFLDTLLQDF	PPM1F	16	P49593
LLLLPSGSVSFTDEN	PTPN13	56	Q12923
LQLAGAVISPSDEDS	OSBPL11	106	Q9BXB4
TDVSLLPAFDAVGQL	OAS3	541	Q9Y6K5
ALEGFSTPLDLDNSV	IPO8	941	O15397
EFEATLGASDPNSLA	MIGA1	281	Q8NAN2
LAQGSSEEEELPSLA	NUTM2D	676	Q5VT03
LDPGTNDSATLDALF	GRIN3B	446	O60391
DEEALNDSIISGTLP	PHACTR3	381	Q96KR7
DNAPTTEALFVALGA	MTCH1	76	Q9NZJ7
TISAGQEDFPSVLLE	RTN4	216	Q9NQC3
ATESIATNIFPLLGD	RTN4	471	Q9NQC3
PLEGDSSLELLTFDN	TARS3	211	A2RTX5
GEAQEVPFALSLSSD	RAB11FIP1	721	Q6WKZ4
DAQALLLGDEAPSSA	RNPEPL1	701	Q9HAU8
LLPTIAFGSLNDENT	SLC4A11	371	Q8NBS3
SNFQEFLELTLGTDP	UVSSA	81	Q2YD98
DSLQTESVPFEGLLS	SEZ6L	521	Q9BYH1
PDEFESGISQALLEL	RPS7	16	P62081
EDTPFSALALAELAS	ALDH5A1	231	P51649
IPDGSENGEFLSLDL	HKDC1	71	Q2TB90
LDSATFASPQDFGLV	LRRC41	621	Q15345
GEELVLTGSNFLPDS	NFATC4	601	Q14934
DGALSPVELQSLFSV	RHOT2	321	Q8IXI1
IDVSPGFDASQLSSE	FBXL18	151	Q96ME1
GTDLDAINPSLTDFD	FOXN1	526	O15353
EEDQADSAFPLLSLG	PREX1	816	Q8TCU6
DLLSEFGQFLPDANS	SIN3A	371	Q96ST3
PSLFFSQQLDLGASE	SIN3B	696	O75182
NELLDLPDTIGNLSS	SHOC2	271	Q9UQ13
ASTAQAGEDAILLPF	SHROOM4	756	Q9ULL8
PLTDGISSFEDLLAN	RXFP2	401	Q8WXD0
LATDSAIDILGFTPE	MYH3	331	P11055
VLPGNEALFSLETAS	MYCBP2	2111	O75592
PDLFASGSTDNLVII	WDR17	96	Q8IZU2
ALEVAAPESQGLDSS	SP6	191	Q3SY56
PLNERGDTDLTFFSE	PLB1	1331	Q6P1J6
DSQIASDGSIPVDFL	PIK3CB	21	P42338
PQDVDLALDSGASLL	RIPK4	476	P57078
LPEEASAQEGELSLS	STK36	891	Q9NRP7
LSSLNSPALFGDQDT	SOX6	481	P35712
PLFLGEEDFSLSATI	SERTAD3	81	Q9UJW9
SGALQLTDLDDFIGP	CIAO3	6	Q9H6Q4
ASLAGEELQAVESSP	CILP	826	O75339
NLIEGSDSPDSFISQ	CNBD1	216	Q8NA66
PGTDDQLRFAASLIS	CHAT	226	P28329
PSGLADEINFEDFLT	TESC	76	Q96BS2
PNDFLTSVVDLIGAA	CNKSR2	121	Q8WXI2
NVTGLDLSDFPALAD	CNOT2	221	Q9NZN8
GISILESSSAFPDNA	TRAF2	81	Q12933
NNSGLPITSAIDLED	SUCLG2	406	Q96I99
VSEDNFEEGSSPTLL	ZBTB21	506	Q9ULJ3
DTETSNDLPKFADGI	ZNF639	61	Q9UID6
AGTQISLADLPFSSE	WWC2	801	Q6AWC2
LSAQLSDPDDFTGLE	UNC80	3196	Q8N2C7
SFLDLSLPVLDDQSG	USP16	381	Q9Y5T5
LASLSIPQLDGTADE	REV3L	516	O60673
FTLEDEPALSTALGS	RP1L1	1631	Q8IWN7
SNLELASASAEFGPE	UBA7	771	P41226
TLELGADFSQVPSVD	PROM2	316	Q8N271
AEGLLTALQPFLSEA	STOML1	291	Q9UBI4
FVPINSVDLDSLGLS	SP3	266	Q02447
APESATVIFAGDTNL	TDP2	251	O95551
EITAPEGSFASADAL	TACC2	2631	O95359
LSAADPGSDLFSVQA	SPTA1	1206	P02549
AGLAFDLNEPSADVS	SMO	601	Q99835
DGSVLLLVSDPSEAQ	TINCR	76	A0A2R8Y7D0
TDSSTQGANLPDFEL	ZC3H4	1031	Q9UPT8
AQEADDAPSISTLGL	ZDHHC11	381	Q9H8X9
ELEGASDPLLSLFGS	UBN1	281	Q9NPG3
RFELLSEPQSGDLTS	WDR55	201	Q9H6Y2
GDSETLTFQALPSRD	PLEKHG2	576	Q9H7P9
EPLENALTVFTDGSS	ERVK-19	461	Q9WJR5
FALDPSVEETAAATL	ZNF407	1876	Q9C0G0
ESLFPTGDELDSSQL	PLD2	6	O14939
FLETVDPELAASGAT	USP7	661	Q93009
DSNGSSDPFVQLTLE	UNC13D	941	Q70J99
FPLSSLANLFEGEDG	TRPV4	31	Q9HBA0
LANLFEGEDGSLSPS	TRPV4	36	Q9HBA0
DANPLDSIDLSSAVF	TBC1D2	86	Q9BYX2
SLDIGNADSLLFTLD	UNC79	1501	Q9P2D8
EGLLDNLVSSDSPLN	LRRCC1	221	Q9C099
NSFDVISDDAFIGLP	LGI1	101	O95970
EDSDFLESGPLAATQ	MZF1	191	P28698